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ACT  Artemisinin-based combination therapy 
C  Fractional number of cycles 
cDNA  Complementary  deoxyribonucleic acid  
Cox  Cytochrome c oxidase 
cytb  Cytochrome b 
DBS  Dried blood spot 
DNA  Deoxyribonucleic acid 
dNTP  Deoxynucleoside triphosphate 
E  Amplification efficiency 
EDTA Ethylenediaminetetraacetic acid 
ELISA Enzyme-linked immunosorbent assay 
G6PD  Glucose-6-phoshpate Dehydrogenase 
HRP2  Histamine rich protein 2 
ID  Iron Deficiency   
IRS  Indoor residual spraying 
LAMP Loop-mediated isothermal amplification 
LLIN  Long-lasting insecticidal net 
NASBA Nucleic acid sequence-based amplification  
MCA  Melting curve analysis 
MgCl2 Magnesium chloride 
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mRNA Messenger- ribonucleic acid 
pLDH  Plasmodium lactate dehydrogenase 
p/µl  parasite per microliter 
PCR  Polymerase chain reaction 
RBC  Red blood cell 
RDT  Rapid diagnostic test 
RFLP  Restriction fragment length polymorphism 
RNA  Ribonucleic acid 
RT-PCR Reverse transcript polymerase chain reaction 
rxn  Reaction 
SNP  Single nucleotide polymorphism 
t  Threshold 
TARE-2 Telomere-associated repetitive element 2 
Tm  Melting temperature 
varATS  var gene acidic terminal sequence 
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1.1 Malaria history and epidemiology 
Malaria is a parasitic vector borne disease, which name derives from the medieval 
Italian expression mal aria meaning ‘bad air’. Ancient romans believed that the 
disease came from the fumes in the swamps. Symptoms of malaria were described in 
ancient Chinese medical writings as far back as 2700 BC. In modern medicine we 
know that malaria is caused by a bite from an infected female Anopheles mosquito [1].  
 
The protozoan parasite belongs to the genus Plasmodium group. In humans five main 
species are described, P. falciparum, P. vivax, P. ovale, P. malariae, and P. knowlesi. 
The latter is a zoonotic species; the main hosts are long-/and pig-tailed macaques 
existing in Southeast Asia, particularly Malaysia [2]. It can be argued for that we have 
six main species infecting humans due to the recent identified two subspecies of P. 
ovale, P. ovale curtisi and P. ovale wallikeri. These two distinct species are sympatric, 
meaning that they co-exist in the same geographical areas [3].           
 
The malaria parasite life cycle is complex and involves various stages in both vector 
and host (Figure 1). In humans, the sporozoites from a mosquito bite first develop in 
liver cells, without causing any symptoms. Thereafter the merozoites enter the 
bloodstream and invade the erythrocytes. P. vivax and P. ovale have the ability to go 
into a dormant, hypnozoite, stage in the liver, and if untreated it can cause relapse by 
invading the bloodstream weeks, or even years later. In the infected red blood cells, 
trophozoites, the parasites undergo asexual multiplication and form schizonts. 
Eventually, these schizonts will cause cell rupture and release 8-32 new merozites [4]. 
The erythrocytic cycle lasts 24-72 hours, depending on the species [5], and in non-
immune individuals symptoms can appear from when the bloodstream parasite density 
exceeds 50-100 parasites per microliter (p/µl) blood. Some of the trophozoites will 
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differentiate into sexual erythrocytic stages called gametocytes. If the gametocytes are 
taken up in the blood meal to a female Anopheles mosquito, the parasites will undergo 
a sporogonic cycle in the gut of the mosquito resulting in sporozoites ready for new 
infections [4].  
 
The red blood cells (RBCs) are produced in the bone marrow, and transport oxygen by 
using haemoglobin. The RBCs use about seven days to mature. Within 120 days they 
are eaten and recycled by macrophages. Typical male adult density of RBCs is about 
five million per microliter. The different Plasmodium species have not all the same 
RBC tropism dependent on restricted RBC receptor preferences. P. vivax, P. ovale and 
P. knowlesi have a cell age tropism to reticulocytes, the young immature RBCs, a 
stage that lasts for 1-2 days. About 1-6% of the RBCs are reticulocytes, less in adults 
than in infants. P. malariae has a tropism for the oldest RBCs, while, P. falciparum 
has a wide range of receptor preferences, allowing for infection of all RBCs regardless 
of cell age [6, 7].  
 
It is less understood how some of the trophozoites change their destiny becoming 
gametocytes, and how this complex sexual stage matures in the host. Studies have 
shown that immature P. falciparum gametocytes migrate to internal host organs such 
as the spleen and in particular the bone marrow for maturation. Only mature micro- 
and macrogametocytes are released back into the blood stream. The number of 
circulating gametocytes is low (~5%) compared to the other parasitic bloodstream 
stages [8, 9].         
 
Malaria is a tropical disease that can cause acute febrile illness. Symptoms appear 7-18 
days after an infective mosquito bite [4]. Almost half of the world’s population is at 
risk of malaria. According to the World Health Organization (WHO) as many as 90 
countries and areas have ongoing malaria transmission [10]. The African region is 
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home for 92% of the global malaria burden’s cases and deaths, followed by South-East 
Asia (5%) and Eastern Mediterranean region (2%). Countries with the largest global 
burden (80%) are in Sub-Saharan Africa, but also India makes the top 15 list. The 
recent years the WHO has reported that over 200 million malaria cases, and 400 000 
deaths occur every year. It’s estimated that children under five years of age account for 
over 60% of these deaths. Complicated malaria and deaths are mainly attributed to P. 
falciparum [10].  
 
Figure 1: Plasmodium parasite life cycle 
 
 
Among the Plasmodium species infecting humans, P. vivax is most widely distributed 
globally [11]. Though, evolution has shown its power in many African countries; 
individuals with negative Duffy antigen status have a natural protection against P. 
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vivax infections. The Duffy antigen is a chemokine receptor expressed on the surface 
of RBCs, particularly reticulocytes, which the P. vivax parasites use to connect 
themselves to the RBCs triggering endocytosis [12]. P. knowlesi parasites also use this 
receptor [13], but since this species is zoonotic, the distribution of P. knowlesi in 
humans is limited to the habitants of macaques. Still, P. knowlesi is widely distributed 
in Malaysia, and severe disease and fatal outcomes are reported [14]. Recent research 
has discovered that P. vivax uses an additional receptor on the reticulocytes called 
Transferrin receptor 1 [15]. Therefore, negative Duffy antigen status does not cover a 
full P. vivax protection [16]. However, this natural protection phenomenon, and the 
less restricted receptor preference, is thought to be the reason why P. falciparum is so 
highly dominating in the African region. According to the WHO, 99.7% of malaria 
cases in Africa in 2017 were estimated to be attributed to P. falciparum [10]. There are 
some geographical exceptions in Africa. Ethiopia for instance, is known for its high 
prevalence of both P. falciparum and P. vivax. Overall P. falciparum is predominating 
in the regions of South-East Asia (63 %), the Eastern Mediterranean (69%), and the 
Western Pacific (72%), but countries within these regions have a greater variation in 
species distribution. There are several geographic areas were P. vivax predominates, as 
well as in the American region (74%) [10]. Some explanations of why P. vivax is so 
widespread, even with the dominance of P. falciparum, are the lower blood-stage 
parasitaemia, fast maturing gametocytes [17], and the ability to establish hypnozoite 
reservoirs [18]. Despite low parasitaemia, P. vivax can cause severe disease that in 
some circumstances may be life-threating [19].  
 
The neglected species of malaria awareness are P. ovale and P. malariae; less is 
known of their receptor preferences, transmission dynamics etc. Both these species are 
rare and usually cause mild disease. P. malariae have a wide global distribution, while 
P. ovale is mostly found in Sub-Saharan Africa and Asia [20-22].  
Furthermore, it is not uncommon that the different species are being found as double 
or triple infections in humans [23]. 
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Other inherited blood conditions such as sickle-cell trait, thalassaemia, glucose-6-
phosphate dehydrogenase (G6PD) deficiency, and ovalocytosis, have also emerged 
through evolution to generate a natural human genetic resistance towards malaria. 
Paradoxically, all of these conditions can cause severe and fatal illness [10, 24].  
 
Both innate and adaptive (acquired) immunity exist in individuals living in malaria 
endemic areas, though, these mechanisms are poorly understood. It is suggested that 
maternal immunoglobulin (infants), and natural killer cells among others are involved 
in the primary line defence against the hosts’ first encounter with a malaria infection 
(innate immunity) [25]. The adaptive immunity involves the immune memory cells’ 
ability to recognize previous malaria infections. Acquired malaria immunity is 
described by three pathways; anti-disease and anti-parasite immunity, affecting 
parasite density and disease severity and morbidity, and premunition, that protects 
against new infections by maintaining low-level parasitaemia. The acquired immunity 
is age-dependent, affected by number of infectious bites, and lost within months when 
leaving endemic areas, or living in areas where transmission ceases [26].        
 
Several studies have investigated malaria related anaemia, a severe and life-
threatening condition, especially among young children. A malaria infection leads to a 
high RBC loss. However, it has been shown that iron deficiency (ID) is associated 
with reduced parasite growth and suppression of malaria superinfections (infections by 
more than one genotype) [27, 28]. The parasite is highly dependent on the availability 
of iron. ID might be a result of the hosts’ attempt to starve the parasites from iron 
supply, although the parasites as well benefit from inhibition of superinfections 
ensuring transmission of their clones [29, 30]. Studies show conflicting results 
regarding a possible association of iron supplements in anaemic children and increased 
malaria risk [31, 32]. A hormone that can cause ID is hepcidin; when up-regulated the 
enzyme indirectly promotes rest in diet iron uptake, directs iron away from the liver, 
and triggers macrophages to store their iron. With low iron level in circulation the 
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RBC replacement by the bone marrow is slow. In typical anaemia hepcidin is 
suppressed, and the bone marrow is stimulated to increase RBC production [30, 33]. 
Studies have shown an up-regulation of hepcidin in malaria infections, though in 
general hepcidin levels are high during inflammations [34]. Therefore levels of ferritin 
and transferrin saturation might be better markers to describe associations between ID 
and malaria protection [35]. 
 
There are numerous commercial drugs against malaria. Chloroquine was developed in 
1934, is a synthetic derivate from Quinine extracted from the South American 
Cinchona tree, and was a very effective and widely used malaria drug for several 
years, until its effectiveness declined due to drug resistance [36]. In the later years 
artemisinin-based combination therapies (ACTs) are recommended by WHO as first-
line treatment regime against uncomplicated malaria [37]. For severe P. falciparum 
infection, it is recommended to give artesunate intravenously. Artemisinin is isolated 
from sweet wormwood, a herb employed in Chinese traditional medicine. It has 
already been reports on decline in artemisinin drug effectiveness [38, 39]. Worldwide 
research on artemisinin resistance is ongoing. Primaquine prevents P. vivax and P. 
ovale relapses [40]. It is also the only malaria drug with an effective gametocytocidal 
activity against mature transmissible P. falciparum gametocytes [41]. However, 
primaquine can trigger haemolysis in individuals with G6PD deficiency [42].   
 
In addition to treatment, some drugs are used for malaria prophylaxis in travellers. The 
most applied ones are atovoquone-proguanil (Malarone), doxycycline and mefloquine 
(Lariam). In endemic areas use of long-lasting insecticidal nets (LLINs) and/or indoor 
residual spraying (IRS) are effective malaria control methods. Over 20 different 
vaccine-projects are being evaluated in clinical or preclinical trials, however due to the 
complexity of the malaria parasite and its life cycle there is currently no commercially 
malaria vaccine with full coverage available. Mosquirix has been on the market since 
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2015, but gives far from 100% coverage, although protects against malaria together 
with other control methods  [10].   
 
1.2 Diagnostic methods 
There are several methods which can be used to diagnose malaria. The methods vary 
in sensitivity and specificity, as well as turnover time and the need for skilled 
personnel, technical equipment and extensive facilities. Some methods are used in 
point of care diagnosis, while others are more suitable as a reference method or 
research.       
   
1.2.1 Routine diagnostics 
Light microscopy of Giemsa-stained blood smear is the traditional routine method for 
diagnosing malaria. The method has a short turnover time, though requires a suitable 
microscope, and skilled personnel. Microscopy allows for species identification and 
quantification of parasitaemia, however over- and under-diagnosis is not uncommon, 
and species might be incorrectly identified [43, 44].     
 
Malaria rapid diagnostic tests (RDTs) are based on immunochromatographic 
methodology, and detect specific antigens produced by malaria parasites in the blood 
[45]. The different antigens are histidine-rich protein 2 (HRP2), which is specific to P. 
falciparum, Plasmodium lactate dehydrogenase (pLDH), which can be panspecific or 
specific to either P. falciparum or P. vivax, and aldolase, which is panspecific. The 
different RDTs can either detect one of these antigens, or a combination. 
Commercially available RDTs differ widely in sensitivity and specificity [46]. 
However, the tests are quick and easy to perform, and recommended as routine method 




1.2.2 Molecular diagnostics 
The limitation of both microscopy and RDT in detecting malaria is low sensitivity and 
specificity [47-49]. Therefore, during the last decades a variety of molecular 
techniques have been introduced for malaria diagnostics, such as enzyme-linked 
immunosorbent assay (ELISA) [50], restriction fragment length polymorphism 
(RFLP) [51], nucleic acid sequence-based amplification (NASBA) [52], polymerase 
chain reaction (PCR) [53], and loop-mediated isothermal amplification (LAMP) [54]. 
The downsides of molecular techniques are the long turnover time, and the 
requirement of skilled personnel, technical equipment and extensive facilities. 
Consequently, within malaria diagnostics these methods are mostly applied for 
surveillance and research purposes. 
 
The techniques PCR and LAMP have been the more popular methods within malaria 
molecular diagnostics. The first malaria PCR was described in 1990 [55], while the 
first malaria LAMP was described in 2006 [56]. Both techniques are based on the use 
of short oligoes, commonly called primers, to amplify a specific target sequence from 
a few to millions of copies for detection. PCR applies two primers, while LAMP uses 
six. The main goal with these highly sensitive and specific methods is to make them as 
suitable as possible for malaria diagnostics under field conditions. Here, the LAMP 
technique might have an upper hand. In theory the target sequence can be amplified by 
sole use of a heating block and the amplified product can be detected by direct staining 
[56]. However, for accurate LAMP sensitivity and specificity, more advanced 
equipment is required. Nevertheless, the main challenges for both LAMP and PCR, to 
achieve high sensitivity and specificity, is the need for extracted DNA as material, and 






1.3 PCR  
PCR is a technique that is performed in three stages; extraction of deoxyribonucleic 
acid (DNA) from material, amplification of a specific DNA sequence, and detection of 
the amplified product (Figure 2).  
 
1.3.1 Extraction of DNA 
Purification of DNA can be executed in several different ways. One of the more 
applied methods is the use of spin columns, where DNA specifically binds to a silica-
gel membrane, while contaminates are washed away [57]. Another method is to use a 
chelex matrix that binds to PCR inhibitors, like divalent cations and proteins, and the 
DNA remains in the supernatant [58].  
 
In performing malaria PCR, the choice of sample material is important, both to 
achieve high sensitivity and to be user-friendly to collect. Typically, the blood is either 
collected in ethylenediaminetetraacetic acid (EDTA) tubes or as a finger prick on filter 
papers. Blood on filter papers, commonly called dried blood spots (DBS), are far 
easier to store and transport than in EDTA tubes, and therefore this collection method 
is increasingly applied in field studies [59]. EDTA whole blood should be stored on     
-20°C as soon as possible, while filter papers should be stored dry and in the dark at 
room temperature [60]. However, the small blood volume (~50 µl) obtained on filter 
papers, limits the sensitivity of the PCR results [60, 61].    
 
1.3.2 Amplification of purified DNA 
The PCR amplification of a specific DNA sequence is executed by three temperature 
steps by a thermocycler machine (Figure 2B). The first step is denaturation, often at 
temperatures 95-98°C, where the double-stranded DNA is separated. The next step is 
annealing, often at temperatures 50-65°C, where two primers bind specifically to the  
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DNA, enclosing the chosen target sequence. The last step is elongation, often at a 
temperature of 72°C, where a thermostable DNA polymerase in the presence of free 
deoxynucleoside triphosphates (dNTPs) and magnesium chloride (MgCl2), synthesises 
new DNA strands complementary to the strands defined by the primers. These three 
steps are then repeated in cycles 20-50 times, ending up with millions of copies of the 
target sequence [62].  
 
There are different types of PCR amplification. For example, reverse transcription 
PCR (RT-PCR) is a technique that can detect gene expression/ribonucleic acid (RNA) 
transcripts levels by primers binding to complementary DNA (cDNA) transcripts from 
messenger-RNA (mRNA) [63, 64]. Another type is nested PCR (Figure 3), where the 
target DNA undergoes two separated amplification processes with two different sets of 
primers. In the second run the amplified product from the first PCR is used as the 
template, and the second pair of primers encloses an inner sequence of this first 
product [65]. This nested design makes the method highly sensitive and specific, but 
also increases the risk of accumulation of PCR products in the laboratory environment. 
Multiplex PCR amplifies two or more different DNA sequences simultaneously in one 
amplification reaction. The technique uses multiple primer sets/pairs, one for each 
amplification target. This process requires that all the primers in the master mix can 
work at the same annealing temperature [66]. However, multiplex PCR often have low 
sensitivity and specificity due to primer competition and unspecific primer 
binding/duplexes [67].  
             
1.3.2.1 Optimization of the amplification 
Because primers and target sequence are unique for each specific amplification 
process, optimization is often needed, or at least beneficial. A perfect balance between 
specificity and sensitivity is the goal. With low specificity other products than the 
wanted target sequence are also amplified, while, with low sensitivity the amplified 
product can be difficult to detect [68].  
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Melting temperature (Tm) is the temperature where one half of a given DNA duplex 
will dissociate to become single stranded. As an example, primer Tm indicates the 
primer-template stability at a given temperature. If the annealing temperature is 
considerably lower than the Tm, the primer will bind strongly, but with an increased 
risk of unspecific binding. If the annealing temperature is considerable higher than the 
Tm, there is an increased risk that the primer will not bind at all, resulting in lower 
sensitivity. Therefore, when deciding the annealing temperature, there is room for 
optimization, as a difference of only one or two degrees can have an impact [69]. 
There is also room for optimization regarding the running-time for each temperature 
step, especially for the annealing and the elongation step. The time for each step must 
be long enough to successfully match the primers with the correct template sequence, 
and amplify the product, but if the running-times are too long, unwanted products may 
also be amplified [68]. The DNA polymerases used in PCR require divalent cations for 
their activity. Commercial PCR master mix kits usually contain MgCl2. However, 
adding extra MgCl2 can have a positive impact on PCR efficiency, and the balance 
between specificity and sensitivity [70]. Other elements to optimize include the 
amount of template, and the primer concentration [68].    
    
1.3.2.2 Amplification target  
 To detect low concentration DNA in the blood, the choice of amplification target is of 
importance [71]. For instance, the genome of a Plasmodium parasite has certain genes 
existing in multiple copies, meaning that the starting point for amplification will be 
different depending on the choice of DNA target. PCR is an exponential reaction, and 
the number of sequences the primers can bind to in the first cycle, will impact the total 
yield. It is also important that the DNA target is a part of a conserved gene, so that 
binding sites for the primers always will be the same and independent of parasite 
origin. The first malaria PCR methods used chromosomal small subunit ribosomal 
RNA 18S locus as target gene, which typically exists in five to eight copies in P. 
falciparum [72]. Thereafter, there was a switch of focus to the conserved Plasmodium 
mitochondrial genome, existing in ~20-160 copies depending on the development 
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stage [73, 74]. A typical target on the mitochondrial genome is the cytochrome b gene 
(cytb) [75]. In 2015 a publication introduced two chromosomal subtelomeric targets; 
the telomere-associated repetitive element 2 (TARE-2), and the var gene acidic 
terminal sequence (varATS). TARE-2 exists in ~250-280 copies, due to 10 to 12 
repeat units presented at 24 of 28 subtelomeric sequences, and the varATS exists in 59 
copies, and encodes the P. falciparum erythrocyte membrane protein 1 [76]. 
 
Figure 3: Principle of nested PCR 
 
 
1.3.3 Detection of amplified DNA 
1.3.3.1 Conventional PCR 
The conventional way of detecting an amplified PCR product is by agarose gel 
electrophoresis, where negative charged DNA molecules migrate through the gel from 
a negative towards a positive charged field. Similar sized DNA molecules will travel 
through the gel at the same speed and form a band. By including a standardized DNA 
ladder it is then possible to interpret the size of the product (Figure 2C). The DNA 
bands are visualized in UV-light when DNA is dyed either with ethidium bromide or 
GelRed [77]. However, the technique is time-consuming, and creates a risk of 
contaminating lab environment with amplified products.   
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1.3.3.2 Real-time PCR 
With real-time PCR the third stage of conventional DNA detection is incorporated into 
the amplification stage. An advanced thermal cycler monitors directly the 
amplification of target DNA for each cycle of the PCR process (Figure 2C), by 
including in the master mix either non-specific dyes that intercalate with double-
stranded DNA, or sequence-specific DNA oligoes that are labelled with a fluorescent 
reporter [78, 79]. 
 
Free in a solution non-specific dyes exhibit only low fluorescence, and this 
background is subtracted during computer analysis. But when bound to double helix 
molecules formed from single-stranded DNA in the amplification step, the emitted 
light from the bound dye increases by over a 1000-fold [80]. Examples of these DNA-
binding dyes are SYBR Green, EvaGreen, SYTO, and LCGreen. SYBR Green will 
inhibit PCR if used in high concentration. The others do not inhibit PCR, and can 
therefore be used in saturated concentrations ensuring that all vacant binding sites are 
bound by dye [81]. However, the low cost and user-friendly SYBR Green has 
traditionally been the more widely applied intercalating dye for real-time PCR 
methods (Figure 4A) [82]. A disadvantage with the non-specific dyes is that they bind 
to any double-stranded DNA, lowering the specificity of the PCR. Optimization is 
therefore important; the specificity relies on a high PCR efficiency, and concentration 
of specific amplified DNA outshining unspecific binding [83]. 
 
A labelled sequence-specific DNA oligo used for real-time PCR can be designed in 
various different ways depending on how the reporter molecule (fluorophore) becomes 
activated. Many act as a third oligo, commonly called a probe. Examples of labelled 
oligoes types are hydrolysis (TaqMan) probes, molecular beacons, dual hybridization 
probes, eclipse probes, scorpions PCR primers, LUX PCR primers, and QZyme PCR 
primers [79]. Typically the principle is that the fluorophore does not convey a signal 
when close to a quencher molecule, but when separated from the quencher during 
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amplification, the fluorophore will release a fluorescence signal for detection [79]. The 
TaqMan probes are the most applied labelled oligoes used for real-time PCR [84], 
named after the videogame Pac-Man as during amplification the Taq Polymerase eats 
up the sequence-specific bound probe releasing the fluorophore from the quencher 
(Figure 4C).    
 
When designing primers for real-time PCR, it is important to consider the length of the 
PCR product. This is in contrast to conventional PCR, where this is not as crucial as 
long as the length is within a standardized DNA ladder. Ideal amplicon length for real-
time assays is 50-150 base pair (bp). Short amplicons give higher PCR efficiency due 
to high stability, low variation, and high precision of the amplification process [78, 
79]. High efficiency is essential since real-time technique is sensitive to background 
noise. With conventional PCR the visual amplicon band can be distinguished and 
confirmed positive from other unspecific products by size. A hydrolysis probe will 
release only one single fluorophore for each amplicon, while the fluorescent signal 
applying intercalating dye will be stronger with more dye incorporated in the longer 
amplicons [85]. In addition, using intercalating dyes a melting curve analysis (MCA) 
can be performed by an additional step in the real-time PCR software program. 
Because each specific amplification product have their own distinct melting curve, 
MCA can identify false positives and primer dimers. The analysis is based on the 
different amplicons having different melting temperatures, and dissociation 
characteristics are monitored by heating of double-stranded DNA (Figure 4B) [86].  
 
1.3.3.3 Quantitative PCR  
In contrast to conventional PCR, the direct detection by real-time allows for 
quantitative results (q-PCR). The main numbers given by real-time PCR software are 
cycle threshold (Ct) values, which is inversely proportional to the amount of target 
DNA in each sample, meaning that low Ct values indicate high parasitaemia, and vice 
versa. A more accurate way to perform q-PCR is to include a known dilution series of  
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target DNA, that will serve as a standard curve to determine the number of target 
copies per volume in the sample [87]. The dilution series can either be made from a 
sample with known number of parasites in known parasite stage or even more exact, a 
sample with customized plasmid including the target sequence [63, 84, 88]. An 
optimal standard curve should include at least four clear positive dots covering the 
whole parasitaemia range of your sample material [89]. The slope value of the 
standard curve gives the amplification efficiency (E). A value of -3.32 indicates a 
100% PCR efficiency [87].  
  
1.4 Sequencing of PCR products  
The nucleotide order of a PCR product can be determined by DNA sequencing. There 
are developed different techniques to sequence a DNA fragment, and most commonly 
applied is the Sanger sequencing, a chain termination method [90]. The process is 
advanced, and requires extensive machines and facilities. In malaria diagnostics and 
research, sequencing is useful for confirming positive PCR products and determining 
the species and strains [91]. In drug resistance surveillance and research, sequencing is 
a necessity; resistance is often associated with specific point mutations on relevant 
parasitic genes that can be identified by sequencing. Certain point mutations on the P. 
falciparum pfcrt gene are associated with Chloroquine resistance [92], and widely 
reported. While specific point mutations on the P. falciparum Kelch 13 propeller 
domain are associated with artemisinin resistance [38], and reported in malaria cases 
from South-East Asia [93]. However, until now these mutations are not found in 
Africa [94], so the surveillance and research on artemisinin resistance is ongoing.       
  
1.5 Malaria parasitaemia 
Malaria PCR can detect extremely low densities of target DNA in blood, and 
compared to microscopy and RDT this technique is superior in sensitivity and 
specificity [48, 95, 96]. A sensitive PCR will detect a broad range of parasitaemia 
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levels, also asymptomatic malaria [97-99]. In general low-level parasitaemia may be 
due to early infection (primary or recurrent), non-falciparum infection, premunition, or 
remains of parasites and denatured DNA after infection clearance by the immune 
system and antimalarial treatment [100, 101]. Gametocytes are less affected by drugs 
and the immune system, and circulate in the blood for weeks after ended parasite life 
cycle pending transmission [102]. A sensitive PCR can be positive for malaria 3-4 
days before microscopy, and thereby detect infection earlier [103]. Dependent by 
amplification target different PCR assays may vary in sensitivity and interpretation of 
q-PCR results with the various Plasmodium blood-stages; from the influence of 
sequestration in peripheral circulation, to the number of gene copies in the 
chromosomal and mitochondrial genome [72-74]. In both malaria diagnostics and 
research it is an advantage to implement q-PCR in order to increase knowledge about 















2. RATIONALE OF THE STUDY 
Microscopy has historically been the number one method to diagnose malaria, and still 
is, but has its challenges in accurate sensitivity and specificity. For many years the 
conventional nested 18S PCR published by Snounou in 1991 was regarded as the gold 
standard for molecular malaria diagnostics. The nested design provided high 
sensitivity and specificity. However, this two-step method is time-consuming and 
increases the risk for contamination. Therefor the need for a competing single-step 
PCR assay was prominent. A way to compete with the high sensitivity of nested PCR 
is to apply another amplification target with a higher copy number than the standard 
target 18S gene.  
 
As PCR became increasingly applied as reference method in malaria research studies, 
there were reports on PCR being a sensitive enough method to not only detect clinical 
cases, but also a high portion of asymptomatic malaria compared to microscopy. In 
recent years, the detection of low parasitaemia has been a hot topic within malaria 
research; in order to increase knowledge of diagnosing acute fever patients, malaria 
epidemiology, transmission, and elimination surveillance. To achieve this knowledge, 
conventional PCR is insufficient, while real-time q-PCR points itself out to be a highly 
relevant technique for this purpose. The challenge also includes how to interpret 










3. AIMS OF THE STUDY 
 
3.1 Primary aims: 
1. To develop a new robust and user-friendly PCR method. 
2. To assess the PCR method on relevant clinical material.  
 
3.2 Secondary aims: 
1. To validate and compare the developed conventional PCR assay(s) with a reference 
nested PCR method (Paper I).   
2. To compare PCR with routine diagnostics (Paper I, II and III). 
3. To determine the malaria prevalence among fever patients in community hospitals 
in India (Paper II). 
4. To optimize and validate the conversion from conventional to real-time PCR (Paper 
III). 
5. To compare the application of different amplification targets (Paper I and III), and 
the use of platform, SYBR Green versus Taq Man probe (Paper III). 
7. To compare the sensitivity of the novel PCR method to different relevant malaria 
real-time PCR assays (Paper III). 
8. To assess application of q-PCR using P. falciparum positive Tanzanian field 







4. MATERIALS AND METHODS 
 
4.1 Study design, sample material, and study sites 
Paper I and III were mainly methodological studies, while the work done in Paper II 
was part of a multi-centre, observational, cross sectional study. 
 
A detailed overview of the patient and reference materials, positive/negative controls 
and plasmids applied in the three papers is given in Figure 5. 
 












The study sites in Paper II (Figure 6) were secondary level community hospitals with 
100 to 500 beds, located in Tezpur (Assam, North East India), Raxaul (Bihar, East 
India), Mungeli (Chhattisgarh, Central India), Ratnagiri (Maharashtra, West India), 
Anantapur (Andhra Pradesh, South India), Oddanchatram and Ambur (Tamil Nadu, 
South India).  
The Benjamin M Pulimood Laboratories for Infection and Inflammation, Department 
of Medicine Unit 1 and Infectious Diseases, Christian Medical College, Vellore, India 
served as study coordinating centre and reference laboratory. 
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4.2 DNA extraction and storage 
All the three papers applied DNA extracted from 200 µl EDTA whole blood material. 
Both blood and extracted DNA material was stored at -20°C prior to application. The 
DNA was purified using QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany) 
according to the manufacturer’s instructions. In addition, Paper III applied DNA 
extracted from filter papers which had been purified using Chelex-100 Molecular 
Biology Grade Resin (Bio-Rad Laboratories, Hercules, CA, USA) as previously 
described [61]. All the DNA material applied in Paper III had been long-term stored at 
-80°C after short-term storage at -20°C.  
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4.3 Conventional PCR 
Three developed/modified PCR assays, two genus-specific and one species-specific, 
were assessed in Paper I. The genus-/ and species-specific nested 18S PCR as 
described by Singh et al. [53], was included as a reference method.  
A detailed overview and description of methods and primers is given in Figure 7, and 
Table 1 and 2.   
Notification; the modified genus-specific 18S PCR is not further discussed in this 
thesis due to focus on the novel genus-specific cytb PCR that is applied in all the 
projects.  
 





All reaction mixtures contained 2 μl of DNA template and 12.5 μl 2X HotStarTaq 
Master Mix (Qiagen) at a total volume of 25 μl. The amplifications were performed by 
using GeneAmp PCR System 9700 (Applied Biosystems, Carlsbad, CA, USA), and 
the PCR products were analysed by electrophoresis using 2% SeaKem agarose gel 
(Lonza, Rockland, ME, USA) with 1X GelRed (Biotium, Hayward, CA, USA). 
 
In Paper II all samples were screened for presence of Plasmodium DNA by the novel 
genus-specific cytb PCR developed in Paper I. In case of discordant results between 
PCR, RDT or routine microscopy, the samples were retested by the genus-specific 
PCR from the extraction step as a quality control. A malaria infection was confirmed if 
two or all of the three PCR parallels were positive. 
All the genus-specific cytb PCR positive samples were further analysed by the 
modified species-specific 18S PCR protocol also assessed in Paper I. Samples negative 
by the species-specific PCR, were repeated by the genus-specific PCR, and the PCR 
products were thereby sequenced for species identification as described in section 4.5. 
Amplifications were done on AB Applied Biosystem veriti 96 well Thermal cycler 
(Applied Biosystems), and products detected by electrophoresis on a 2% SeaKem 
agarose gel (Lonza) stained with ethidium bromide. 
 
4.4 Real-time PCR 
In Paper III the conventional cytb PCR developed and applied in papers I and II was 
converted into two real-time assays, one using SYBR Green and one TaqMan probe. 
A detailed overview and description of methods and primers is given in Figure 7, and 


















F: rPLU 6 
R: rPLU 5 
1 µM 4 mM 
Step 1, 95°C for 15 min; step 2, 
denaturation at 95°C for 10 sec; 
step 3, annealing at 63°C for 10 
sec; step 4, extension at 72°C for 
75 sec; steps 2-4 repeated 50 






F: PgMt19 F3 
R: PgMt19 B3 
1 µM 4 mM 
Step 1, 95°C for 15 min; step 2, 
denaturation at 95°C for 10 sec; 
step 3, annealing at 62°C for 10 
sec; step 4, extension at 72°C for 
15 sec; steps 2-4 repeated 50 
















F: P. falciparum 
 
F: P. vivax 
 
F: P. ovale 
 

























Step 1, 95°C for 15 min; step 2, 
denaturation at 95°C for 10 sec; 
step 3, annealing at 65°C for 10 
sec; step 4, extension at 72°C for 
30 sec; steps 2-4 repeated 45 





F: PgMt19 F3 
R: PgMt19 B3 
600 nM 1 mM 
Step 1, 50°C for 2 min; step 2, 
95°C for 10 min; step 3, 
denaturation at 95°C for 15 sec; 
step 4, annealing at 59°C for 50 
sec; and step 5, amplification at 






F: PgMt19 F3 





Step 1, 50°C for 2 min; step 2, 
95°C for 10 min; step 3, 
denaturation at 95°C for 15 sec; 
step 4, annealing at 59°C for 50 
sec; and step 5, amplification at 
72°C for 10 sec, steps 3-5 repeated 
45 times 














rPLU 6 forward 5′-tta aaa ttg cag tta aaa cg 20 25 [65] 
rPLU 5 reverse 5′-cct gtt gtt gcc tta aac ttc 21 43 [65] 
PgMt19 F3 forward 5′-tcg ctt cta acg gtg aac 18 50 [108]  
PgMt19 B3 forward 5′-aat tga tag tat cag cta tcc ata g 25 32 [108]  
P. falciparum forward 5′-aac aga cgg gta gtc atg att gag 24 46 [66]  
P. vivax forward 5′-gag cgt tca aag caa aca ga 23 39 Paper I 
P. ovale forward 5′-ctg ttc ttt gca ttc ctt atg c 22 41 [66]  
P. malariae forward 5′-cgt taa gaa taa acg cca agc g 22 41 [66]  
Species-specific reverse  5′-gta tct gat cgt ctt cac tcc c 22 50 [66]  
PgMt(28)-Probe 
6-FAM-ctt cta aca ttc cac ttg ctt 
ata act g-BHQ-1 
28 36 Paper III 
The primers were obtained from Eurogentec (Seraing, Belgium), analysed using Oligo v6 
primer analysis software (Molecular Biology Insights, Cascade, CO, USA), the sequence 
alignment editor software BioEdit v7 (Tom Hall, Carlsbad, CA, USA), and tested with Basic 
Local Alignment Search Tool (BLAST, National Center for Biotechnology Information, 
Bethesda, MD, USA). 
 
A sensitivity comparison including five relevant real-time PCR assays (details given in 
Table 3) was also performed in Paper III. The included assays were applied as 
previously published except from a few fixed parameters as described below.    
All the real-time assays run in Paper III applied 2 µl DNA template, and 12,5 µl SYBR 
Select Master Mix/ TaqMan Universal Master Mix II, with UNG (Applied 
Biosystems), at a total volume of 25 µl. The amplifications were performed using ABI 
Prism 7900HT Sequence Detection System (Applied Biosystems) with the threshold 
automatically set. For the SYBR assays melting curve analysis was included given by 
the program SDS 2.3 (Applied Biosystems). 
Quantitative PCR was performed applying customized plasmid with cytb 220 bp insert  
(OriGene Technologies, Rockville, MD, USA) in a 10-fold dilution series, range 2.7 x 
108 – 2.7 copies of target DNA/reaction (rxn). 
41 
 








Platform Year Reference 
1 Lefterova Pan Chrom 18S rRNA 317 bp SYBR 2015 [91] 
2 Xu Pan Mito cytb 430 bp SYBR 2015 [51] 
3 Farrugia Pan Mito cytb 203 bp TaqMan 2011 [75] 
4 Hofmann P.f Chrom TARE-2 93 bp SYBR 2015 [76] 
5 Hofmann P.f Chrom varATS 65 bp TaqMan 2015 [76] 
Abbreviations: P.f, Plasmodium falciparum; Chrom, chromosomal; Mito, mitochondrial; 
cytb, cytochrome b gene; telomere-associated repetitive element 2, TARE-2; var gene acidic 
terminal sequence, varATS.   
 
4.5 Sequencing 
All the three papers present species-specific PCR results obtained by sequencing. For 
Paper I all positive products by the developed genus-specific cytb conventional PCR 
were sequenced in both directions using the primers PgMt19 F3&B3. The PCR 
products were purified with ExoSAP-IT (USB Corporation, Cleveland, OH, USA) 
according to the manufacturer’s instructions, prior to applying the following cycle 
conditions using GeneAmp PCR System 9700 (Applied Biosystems): step 1, 96°C for 
10 sec; step 2, 62°C for 5 sec; step 3, 60°C for 4 min; steps 1-3 repeated 27 times. The 
reaction mixture contained 1 μl BigDye v1.1 (Applied Biosystems), 2 μl sequencing 
buffer 5X (Applied Biosystems), 0.5 μM primer, and 1 μl template to a total volume of 
10 μl. The sequences were obtained with the ABI PRISM 3730 DNA Analyzer 
(Applied Biosystems), and the BioEdit v7 was used prior to sequence identification by 
BLAST. For Paper II only positive genus-specific PCR products that were negative by 
the species-specific PCR were sequenced in one direction completing the species 
identification, while for Paper III all the genus-specific cytb SYBR PCR positive 







All the three papers compared PCR and microscopy results. The microscopy results 
presented in papers I and II were part of routine work-up according to hospital 
procedures, while the microscopy results presented in Paper III were obtained from 
thin blood research slides which had been stained with Giemsa 5% for 20 min after 30-
sec fixation with 100% methanol.   
 
4.7 RDT 
Papers II and III compared RDT data with PCR results.  
For Paper II the RDT ParaHIT-Total Ver. 1.0 Device 55IC204-10 (Span Diagnostics 
Ltd, Surat, India) was applied on EDTA whole blood stored at -20°C following 
manufacturer’s instructions. The test detects P. falciparum specific HRP2 and aldolase 
antigen of pan-malaria species (P. falciparum, P. malariae, P. vivax, and P. ovale). A 
red band in the ‘Pf’ region alone indicates that the sample is reactive for P. falciparum 
(usually in case of low parasitaemia), while red bands in both ‘Pf’ and ‘Pan’ region 
indicate either single infection by P. falciparum or a mixed infection of P. falciparum 
with one of the other species. Appearance of a red band in the ‘Pan’ region alone 
indicates that the sample is reactive for infection by a non-falciparum species. 
In Paper III we used RDT data produced for the study by Strøm et al. [48]. The RDT 
applied was the First Response Malaria Ag pLDH/HRP2 Combo card on EDTA whole 
blood stored at -20°C following manufacturer’s instructions. In two separate regions 
the test detects HRP2 for P. falciparum and pLDH for pan-malaria species (P. 
falciparum, P. vivax, P. ovale and P. malariae).   
 
4.8 Statistical analysis 
In Paper I we compared the different PCR methods by applying prtest command using 
Stata 11 (Stata Corp, College Station, TX, USA). The differences in sensitivity and 
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specificity with 95% confidence intervals (95% CI) were calculated, and non-inferior 
of the test was considered proved if the upper boundary of the 95% CI of the 
sensitivity difference was less than a predefined delta of 5%. 
In Paper II confidence intervals for tests’ sensitivities, specificities, and positive and 
negative predictive values were calculated using the cii command in Stata 14, and 
presented as exact 95% confidence intervals. 
In Paper III both the statistical univariate and the multivariate logistic regression 
analysis were performed applying IBM SPSS Statistics version 24 (SPSS Inc., IBM 
Company). For the univariate analysis the data were organized into categorical 
variables for 2x2 cross-tabulation analysis, and assessed with effect estimates (odds 
ratio) with corresponding confidence intervals, as well as Chi-squared test, or Fisher’s 
exact test if few observations. For the multivariate analysis the p-values were 
calculated by the Likelihood ratio test using SPSS and QuickCalcs (GraphPad 
Software). In the regression model, all variables with p-value <0.1 from the univariate 
analysis, excluding variables with extensive numbers of missing values, were 
included, and the model was evaluated by the Hosmer and Lemeshow Test, and by 
residuals and Cook distances analysis. For both the univariate and the multivariate 
analysis, a correlation was regarded as statistically significant if p-value was < 0.05. 
 
4.9 Ethical considerations 
Both the projects presented in Paper I and III were approved by the Regional 
Committee for Ethics in Medical Research (REK) in Bergen, Norway (No.2011/942 
(Paper I), No.2015/886 and 2016/584 (Paper III)), while the project presented in Paper 
II was a collaboration between Haukeland University Hospital and Christian Medical 
College, approved by both REK (2010/2271-5) and the Institutional Research Board at 
Christian Medical College, Vellore, Tamil Nadu (No. 7242 dated 11th of August 




5. SUMMARY OF RESULTS 
Flowcharts over the main results from papers I, II and III are given in Figure 8. 
 
5.1 Paper I 
A novel, single-amplification PCR targeting mitochondrial genome highly 
sensitive and specific in diagnosing malaria among returned travellers in Bergen, 
Norway 
Christel G Haanshuus, Stein Christian Mohn, Kristine Mørch, Nina Langeland, Bjørn 
Blomberg, Kurt Hanevik 
Malar J. 2013 Jan 22;12:26. 
Plasmodium genus-specific detection: In this study we design a novel genus-specific 
PCR that for positive samples amplifies in one step a 220 bp long amplicon by using a 
target sequence on the mitochondrial cytb gene. The cytb PCR showed a high 
sensitivity and specificity compared to routine microscopy and reference nested 18S 
PCR. Among a Norwegian sample collection (N=135) from fever patients with 
potential imported malaria, a consensus of true malaria positive samples were defined 
by at least two out of three methods positive, 21% (28/135). The cytb PCR had a 100% 
sensitivity (28/28), nested 18S PCR 96% (27/28), and microscopy 93% (26/28). A 
dilution of 0.5 ring stage parasite/µl (reference material) run in 30 parallels 
differentiated the two highly sensitive PCR methods; cytb PCR 97% (29/30) and 
nested 18S PCR 87% (26/30). Both methods detected as low as 0.05 p/µl, but not 
consistently.   
Plasmodium species-specific detection:  In addition to developing a genus-specific 
cytb PCR, we also modified and optimized a species-specific single-step 18S PCR, 
which was 100% sensitive and specific compared to species-specific nested 18S PCR. 
Furthermore, the 28 positive genus-specific cytb PCR products were sequenced to 
confirm true positivity, revealing six single nucleotide polymorphisms (SNPs) and one 
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insert/deletion allowing for species determination of the 28 sequences. Overall there 
were seven samples (six patients) with discordant results between the different 
methods. Routine microscopy overlooked one P. malariae, and one P. vivax infection. 
One recurrent (relapse) P. vivax infection was inconclusive by microscopy, while two 
single infections, one P. ovale and one P. vivax, were interpreted by microscopy as 
double infections with P. falciparum. In one double P. falciparum and P. malariae 
infection, microscopy under-diagnosed the P. malariae. Sequencing of the cytb PCR 
products also missed the P. malariae in the double infection. One recurrent 
(recrudescence) P. falciparum infection was positive by microscopy; one ring stage 
parasite was detected. Positive as well by the cytb PCR sequencing, while none of the 
18S PCR assays detected this infection. The discordant results showed how important 
it is to include PCR as a reference method for microscopy. 
 




5.2 Paper II 
A High Malaria Prevalence Identified by PCR among Patients with Acute 
Undifferentiated Fever in India 
Haanshuus CG, Chandy S, Manoharan A, Vivek R, Mathai D, Xena D, Singh A, 
Langeland N, Blomberg B, Vasanthan G, Sitaram U, Appasamy J, Nesaraj J, Henry A, 
Patil S, Alvarez-Uria G, Armstrong L, Mørch K 
PLoS One. 2016 Jul 7;11(7). 
Plasmodium genus-specific prevalence: This study was a part of a large multicentre 
study investigating causes of acute undifferentiated fever (N=1564). Seven community 
hospitals in six states of India were included, and 1412 samples were available for 
malaria PCR testing. In total 19% (268/1412) was positive by genus-specific cytb 
PCR. The seven sites had a prevalence as following; Oddanchatram (South India) 6% 
(19/318), Ambur (South) 16% (44/274), Tezpur (North-East) 17% (49/293), 
Anantapur (South) 23% (28/124), Mungeli (Central) 25% (13/52), Raxaul (East) 28% 
(30/106), and Ratnagiri (West) 35% (85/245).  
Plasmodium species-specific prevalence: Among the 268 genus-specific cytb PCR 
positives, 251 samples were available for species-specific 18S PCR. Overall, 46% P. 
falciparum and 38% P. vivax single infections were detected, while P. falciparum and 
P. vivax double infection was found in 11%. Mungeli (85%), Raxaul (79%) and 
Anantapur (52%) had a predominance of P. falciparum, while Ambur (55%) had a P. 
vivax predominance. Tezpur, Ratnagiri and Oddanchatram had a more equal 
distribution of P. falciparum and P. vivax. P. malariae was found in 5% of the malaria 
cases, and all the sites except Mungeli and Raxaul detected P. malariae infections. P. 
ovale was not found in any site.  
Performance of routine microscopy and RDT compared to PCR: Sensitivity by 
microscopy (N=1168) was 29% (66/228), and by RDT (N=1407) 24% (65/268). The 
specificity was high for both methods; 98% (918/940) by microscopy, and 99% 
(1129/1139) by RDT.  Only 5% (2/43) were negative by PCR among both microscopy 
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and RDT positives. From confirmed PCR positive samples, microscopy found a 
malaria prevalence of 6%, and RDT 5%. The number of false positive blood slides by 
microscopy was 22. However, 18 of these were from the same site, indicating a high 
specificity of routine microscopy in six of the seven hospitals. At species level, routine 
microscopy had a tendency to misdiagnose P. falciparum as P. vivax, while there was 
a high specificity in correctly identifying P. vivax infections. None of the P. malariae 
infections were found by microscopy. Among the RDT positives, seven P. falciparum 
infections were misclassified as non-falciparum. Neither did RDT detect any of the P. 
malariae single infections (N=9).  
 
5.3 Paper III 
Assessment of malaria real-time PCR methods and application with focus on low-
level parasitaemia 
Christel Gill Haanshuus, Kristine Mørch, Bjørn Blomberg, Gro Elizabeth Ann Strøm, 
Nina Langeland, Kurt Hanevik, Stein Christian Mohn 
PLoS One. 2019 Jul 5;14(7). 
Conversion from cytb conventional to real-time PCR: By optimization, the genus-
specific cytb conventional PCR (Paper I) was successfully converted to a real-time 
PCR assessed by using reference material, a Norwegian collection (N=113) and 
Tanzanian field material (N=111). Applying SYBR Green to detect positives showed a 
higher sensitivity and specificity than using TaqMan probe. The sequencing of cytb 
SYBR 220 bp amplicons (N=33) confirmed that these real-time PCR products gave 
high-quality sequences of full length, and correctly identified the species at the same 
level as its conventional counterpart method (Paper I).         
Sensitivity comparison of seven real-time PCR assays: Applying low dilutions of P. 
falciparum reference material (5-0.05 p/µl) run in 12 parallels establishing 
reproducibility with low-level parasitaemia; this study cytb SYBR PCR, Xu et al. cytb 
SYBR PCR, and Hofmann et al. varATS TaqMan PCR showed highest sensitivity 
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among the seven real-time assays. Furthermore, by applying the collection of P. 
falciparum positive Tanzanian field samples (N=111), the varATS TaqMan PCR was 
slightly more sensitive than this study cytb SYBR PCR, 86% (96/111) versus 82% 
(91/111).      
Application and assessment of q-PCR: To present an alternative and relevant 
application of q-PCR data, the association between low-level parasitaemia identified 
by the cytb SYBR q-PCR and clinical and demographic factors (N=74), were 
evaluated applying cross tabulation and multiple logistic regression analysis. The 
results are presented in Figure 8C. 
 

























6.1 Development and optimization of PCR methods 
 
6.1.1 Development of a new single-step conventional PCR (Paper I) 
At the time this study started the gold standard for malaria PCR was considered to be 
the genus- and species-specific nested 18S PCR published by Singh et al. in 1999, 
modified from the nested PCR presented by Snounou et al. in 1993 [53, 65]. A highly 
sensitive and specific method due to the nested design, but compared to a single-step 
PCR, twice as costly, long turnover time, and risk of technical errors and 
contamination. Amplification targets on chromosomal small subunit ribosomal RNA 
18S locus are expected to be in 5-8 copies per parasite nucleus [72]. A target with a 
high copy number should give a higher sensitivity [71]. For example with 18S, if the 
blood concentration was one ring-stage p/µl, using 2 µl template gives the exponential 
reaction a starting point of 10-16 copies. Theoretically, one single copy of target DNA 
is enough for detection, statistically, a positive amplification needs a minimum of three 
copies/rxn for reproducible results, but practically, about 10 copies/rxn is of the lower 
limit [106, 107].  
 
The single-step malaria PCR developed for Paper I applied two of the six LAMP 
primers published by Polley et. al [108]. This LAMP was genus-specific, targeting all 
the human Plasmodium species. Although the various Plasmodium species have 
distinct differences in morphology, execution of the erythrocytic cycle etc., their 
genomes are nearly identical, especially for conserved genes. The amplification target 
was a sequence on the mitochondrial cytb gene, which encodes the main subunit of a 
transmembrane complex involved in electron transport, pumping proton to generate 
ATP. The 6 kb mitochondrial genome consists of only three genes in one copy each, 
Cytochrome c oxidase subunit 1 (Cox I), Cox III and cytb, but one mitochondrion 
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harbours about 20 copies of the genome [73]. Ring-stage parasites have one 
mitochondrion [74]. However, gametocytes are reported to have up to eight fold higher 
quantity of the mitochondrial genome, ~160 copies [74, 109, 110], probably because 
the sexual gametocytes have a higher demand for energy and are more metabolic 
active than the asexual stages [74]. Only the female gametes inherit the mitochondrial 
genome, and the sex ratio in the blood circulation is in favour of the female gametes 
[111, 112]. 
 
When designing primers for PCR method development, it is important that the two 
primers have suitable Tm. Factors as the length, GC-content, next neighbour 
phenomenon, and salt concentration, have an effect on the primer Tm [113]. The two 
LAMP primers chosen to design a new single-step PCR had the following Tm; 59°C 
(18 bases, 50% GC) and 60°C (25 bases, 32% GC), calculated by the program Oligo 
(Molecular Biology Insights). Since it was only one degree separating the two primers, 
they had a close affinity to the primer sites at the same annealing temperature, which is 
a great advantage. Optimal Tm of primers is 60-64°C, so the Tm of the chosen primers 
were on the lower limit of optimal Tm. However, in the optimization process it was 
still room for testing high annealing temperatures to adjust for higher specificity 
avoiding unspecific primer binding, and lower temperatures to adjust for higher 
sensitivity. During a long optimization process, an annealing temperature interval from 
56-66°C was tested.  
 
The two LAMP primers had a distance between each other enclosing an amplicon of 
220 bp, which is a perfect amplicon size for conventional PCR. With short amplicons 
the elongation time can be reduced, and amplification precision increases, but 220 bp 
was still long enough to give a strong visible band on an agarose gel within a 100 bp 
DNA ladder. The cytb PCR program was designed with many cycles (50) for high 
sensitivity, but with short time-steps for high precision (10-15 sec). Because of the 
many cycles, the annealing temperature that gave the best results was 62°C. The high 
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annealing temperature and the short time-steps allowed for further increasing the 
sensitivity by using high concentrations of primers (1 µM) and additional MgCl2 (4 
mM) in the master mix. MgCl2 increases the activity of the polymerase, although, 
excess concentration can lead to the enzyme having a lower fidelity [114]. The end 
result of the optimization was a robust PCR program suited for the chosen primers, 
giving a highly sensitive and specific amplification of target sequence applying only 
one amplification step.    
 
The short amplicon length also contributed to that the PCR products easily could be 
sequenced, giving high-quality sequences confirming true positives. The sequencing of 
the 28 positives using BLAST revealed six SNPs and one insert/deletion, which could 
be used to distinguish between the four species P. falciparum, P. vivax, P. ovale and P. 
malariae. The latter species had as much as a four SNPs difference from the other 
species, while P. falciparum and P. vivax had two SNPs. P. ovale had an extra T-
nucleotide in its sequence, which none of the other species had. We did not have the 
expertise to investigate if these SNPs and the extra nucleotide had any effect on the 
reading frame for the protein synthesis of the cytb gene, nor had the opportunity to 
evaluate further if the SNPs are universal in different strains of the species. This 
sequencing technique has later been applied in other malaria studies [48, 115, 116], 
without detecting any deviations to the concerned SNPs. In the Paper I project we used 
both forward and reverse primers to sequence the products, but the sequences had such 
high quality that with the other publications the sequencing was only performed in one 
direction, cutting the cost in half.  
 
A weakness of the sequencing technique is the detection of mixed infections. In 
theory, a mixed infection has the potential to be detected by sequencing due to visible 
double (or triple) peaks were the SNPs are located, but this depends upon that both 
variants of the PCR product are presented in relatively equal quantity. In our 
Norwegian material we had only one double infection with P. falciparum and P. 
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malariae. In this case we could not identify any double peaks, probably due to the P. 
falciparum predominance compared to low-level P. malariae parasitaemia. Looking at 
the results from Paper II, where sequencing was performed on positive cytb PCR 
samples, which the species-specific 18S PCR failed to detect, we found cases showing 
double peaks equivalent to mixed infection of P. falciparum and P. vivax. 
Contamination could not be ruled out, but ambiguous samples were sequenced twice 
for quality assurance.  
 
The sequencing could potentially also identify P. knowlesi infections. P. knowlesi is 
genetically very alike P. vivax, and for our 220 bp amplicon, only one SNP 
differentiate these two species. Therefore, this SNP’s position needs to be evaluated 
carefully to not misinterpret a P. knowlesi as a P. vivax and vice versa. Because the 
spread of P. knowlesi is restricted to specific areas, the species can often be excluded 
based on information of possible infection site. Applying the sequencing method in the 
Paper II-project showed distinct peaks in the SNP’s positions even with very low-level 
parasitaemia simplifying the interpretation of the sequences. The method has proven 
itself to be a powerful tool to be used for species determination when species-specific 
18S PCR is not sensitive enough to detect low-level parasitaemia or with ambiguous 
results by species-specific PCR.   
 
Relevant competing conventional PCR methods targeting the mitochondrial genome, 
are Cunha et al. 2009 applying P. falciparum-specific cox III target (single-step PCR) 
showing a 100% sensitivity compared to microscopy [117], Steenkeste et al. 2010 
targeting genus-specific cytb (nested PCR) showed similar sensitivity and specificity 
compared to nested 18S PCR [118], Isozumi et al. 2014 targeting genus-specific cox 
III (conventional PCR) detected 10-50% more cases compared to standard 18S PCR 
[119], and Echeverry et al. 2016 applying genus-specific cox III direct single-step PCR 
detected three more cases out of 21 than nested 18S PCR [120]. The Steenkeste genus-
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specific PCR products can be species identified by using restriction fragment length 
polymorphism-denaturing high performance liquid chromatography (RFLP-dHPLC).  
 
6.1.2 Modification of a species-specific multiplex 18S PCR (Paper I) 
A major challenge with species-specific malaria PCR are the genetical similarities in 
conserved genes which might result in unspecific primer binding and reduced 
specificity. Applying conserved genes as PCR target is important; the target has to be 
specific to the relevant species, but also work on all variant of strains from different 
geographically areas. The different Plasmodium species have almost identical 
sequences for conserved genes with often only sporadic SNPs separating the 
sequences.  
 
In 2003 a species-specific multiplex 18S PCR was published by Padley et al. [66]. 
This multiplex PCR targeted the four species P. falciparum, P. vivax, P. ovale and P. 
malariae, by applying a common reverse primer and species-specific forward primers. 
However, as with all multiplex PCR assays; the effect of competing primers and 
reactions is always an issue. Therefore, we decided to modify the multiplex PCR by 
amplifying target sequences in separated reactions instead of one reaction. This 
increased cost, logistics and working-hours, but reduced the risk of cross-bindings due 
to similar primer sites. The product size of the four different amplicons was also quite 
alike making it difficult to interpret the multiplex results on agarose gels. Between P. 
vivax and P. falciparum amplicons there was only a 24 bp difference, and a difference 
of 37 bp between P. ovale and P. malariae. Nevertheless, running the species-specific 
primers in separate reactions, we still experienced cross-binding of the P. vivax primer 
to high parasitaemia P. falciparum infections. We therefore decided to design a new P. 





The six hour multiplex PCR program consisted of 43 cycles with extreme long time-
steps; 45 sec denaturation, 90 sec annealing, and 5 min elongation time. The long 
time-steps increases the sensitivity, but also the risk of cross-bindings. We went for 
another strategy when designing a common PCR program for all the four reactions; 45 
cycles with 10 sec denaturation and annealing steps, and 30 sec elongation (two hour 
running time). In addition we went for a high annealing temperature 65°C versus 60°C 
in the original program (the species-specific primer Tm values varied from 62°C to 
69°C). When performing species-specific malaria PCR a high specificity is a must, 
more than achieving high sensitivity. However, since each primer pair was in 
separated reactions, we found a balance between sensitivity and specificity by 
individually adjusting for primer concentration and additional MgCl2. The end result 
was a modified species-specific 18S PCR which showed to be as sensitive and specific 
as the species-specific nested 18S PCR [53]. After being assessed in Paper I, our 
species-specific PCR has been applied for identifying species prevalence in three other 
publications [48, 115, 116]. 
 
Relevant competing species-specific PCR methods are Rougemont et al. 2004 a real-
time 18S PCR applying four different species-specific probes [121], Mangold et al. 
2005 a real-time SYBR 18S PCR using MCA to differentiate between four species 
[122], Chew et al. 2012 a single-step hexaplex conventional 18S PCR targeting all five 
species [123], Kamau et al. 2013 a duplex (P. falciparum and P. vivax) real-time 
TaqMan 18S PCR [124], and Reller et al. 2013 a multiplex real-time TaqMan PCR 
targeting 18S (P. falciparum), AMA1 (P. vivax) and plasmepsin (P. ovale, P. 
malariae, and P. knowlesi) [125]. All of these methods varied in sensitivity and 
specificity depending on species or if the infection was single or mixed. Two newer 
methods are Saito et al. 2018, a multiplex single-tube nested PCR targeting 
mitochondrial cox III, where detection is performed by single-stranded tag 
hybridization chromatographic printed-array strip with a 89% sensitivity and 100% 
specificity compared to standard nested PCR [126], and Komaki-Yasuda et al. 2018, a 
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nested 18S PCR detecting all five species using a fast PCR enzyme reducing reaction 
time with results highly consistent with microscopy [127]. 
  
6.1.3 Conversion of conventional to real-time PCR (Paper III) 
During this study period there was a change of focus on malaria PCR. In the beginning 
the attention was on presenting a sensitive and specific PCR as a reference method for 
microscopy and RDT. The performance of routine diagnostics was questionable, and 
there was a need for a more accurate method which could reveal true answers. 
However, as PCR methods were more and more included in malaria research studies, 
it was discovered that PCR detects on average twice as many malaria infections as 
microscopy [98]. Our genus-specific cytb conventional PCR was applied in studies 
from Tanzania [48] and India (Paper II), where the PCR detected as much as 72% 
(55/76, N=304) and 71% (162/228, N=1168) submicroscopic malaria respectively. 
Consequently also our focus went to question what this portion of submicroscopic 
low-level parasitaemia actually represents, and if the quantitative results could 
differentiate between clinical cases and asymptomatic malaria.              
 
Therefore to keep up with the ongoing change of focus on malaria PCR, we needed to 
convert our conventional cytb PCR into a real-time q-PCR. The amplicon size of 220 
bp is on the higher limit of what is optimal for real-time PCR; usually the amplicon 
size is 50-150 bp. One of the differences between real-time and conventional PCR is 
that the Ct values are detected in the exponential phase of the amplification, while the 
conventional PCR shows the product from the end-point plateau phase. Precise 
detection in the exponential phase is reliant upon high PCR efficiency with low 
variation and high precision. Short amplicons have less risk of errors than longer 
amplicons. However, our amplicon size of 220 bp was still within the limits of 
conversion to real-time PCR, especially when considering the advantage of sequencing 
the genus-specific PCR product for species identification.  
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A real-time PCR program is less adjustable than a conventional PCR program, due to 
the detection of targets during the exponential phase versus detecting an end-point 
result. A standard real-time program is mostly used; 40 cycles of 95°C for 15 sec, and 
60°C for 1 min, no elongation step. The Taq polymerase still has a high activity at 
60°C, so the real-time PCR principle is that the whole amplification process occurs at 
the annealing stage. The primers bind, and then the polymerase immediately starts the 
elongation step, preferably amplifying a short sequence. For every cycle the amount of 
amplified target is registered, and a positive sample will separate itself from negatives 
by an increased fluorescence signal above the automatically generated threshold.  
 
It is recommended that with long amplicons the elongation step at 72°C is included. 
We followed this recommendation, and the sensitivity was increased by including a 10 
sec elongation step. However, we still needed to adjust for an even higher sensitivity 
ensuring detection of low-level parasitaemia by lowering the annealing temperature 
with one degree, and apply 45 cycles instead of only 40. To balance the high 
sensitivity with also achieving high specificity, we reduced the primer concentration 
(600 nM) and additional MgCl2 (1 mM) compared to the conventional PCR assay. Our 
conventional cytb PCR was successfully converted to both a SYBR and a TaqMan 
probe real-time assay. Regarding design of a TaqMan probe, the Tm of probes should 
be 6-8°C above the Tm of the primers, since it is important that the probe has attached 
to the target sequence before the primers bind and initiate Taq polymerase activity. 
Our probe had a Tm of 5-6°C above the primers (28 bp, 36% GC). 
   
Relevant competing real-time PCR methods targeting the mitochondrial genome are 
Farrugia et al. 2011 applying TaqMan probe targeting cytb [75], and Xu et al. 2015 
applying SYBR green and also targeting cytb [51]. Relevant competing real-time PCR 
methods using other multi-copy targets are Lefterova et al. 2015 applying SYBR 
targeting 18S [91], and Hofmann et al. 2015 applying subtelomeric targets presenting 
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one SYBR TARE-2 and one TaqMan varATS assay [76]. All of these methods were 
included in the sensitivity comparison in Paper III.        
 
6.1.4 Quantitative PCR (Paper III) 
The obvious difference between conventional and real-time PCR is the technique of 
detecting the PCR products. With real-time PCR, not only is the detection incorporated 
into the amplification stage, but real-time registrations also allows for quantitative 
values. Ct results present the fractional number of cycles (C) required to generate the 
fluorescence signal exceeding an arbitrary threshold (t), meaning that the fluorescence 
is not a direct measurement of the number of amplicons of the last cycle, but 
cumulatively reflects the fluorescence generated during all previous cycles. The 
threshold is typically automatically set by the software based on the volume of 
background signals. Since the background varies, the threshold also varies, not only 
between different PCR assays, but also between different runs using same template 
and assay. Therefore, comparing Ct values between assays and runs may be 
misleading.  
 
Although Ct values give a perception of quantity, the values do not portray the level of 
parasitaemia. High Ct values reflect low levels of target DNA in the template, and vice 
versa. For precise quantification of parasitaemia in malaria positive samples, a 
standard curve should be applied, preferably using a customized plasmid for highest 
accuracy. With a customized plasmid you will be able to calculate the exact number of 
copies per reaction (rxn). In clinical parasitology, the parasitaemia is often given by 
percentage (microscopy) or p/µl. However, since PCR detects DNA, and more 
precisely, the number of target sequences in the template, it can be complicated to 
directly convert the number of target copies/µl over to p/µl due to the complexity of 
the malaria parasite lifecycle. Firstly, it depends on the chosen amplification target. 
Chromosomal targets will have the same copy number per parasite nucleus, but since 
some of the parasite stages harbour more than one nucleus (Figure 1), it will not be 
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theoretically correct to present the results as p/µl. A few publications have started to 
use the definition parasite nucleus/µl. With amplification targets on the mitochondrial 
genome the definition of parasitaemia is even more complicated, because some of the 
different parasite stages might not harbour the same number of mitochondrion clusters 
[74, 110]. Therefore, with malaria q-PCR the most precise way to present parasitaemia 
will be by the definition copies/rxn. We have in our papers used p/µl when presenting 
results applying reference material. The reference material consisted exclusive of ring-
stage parasites, and this parasite stage harbours only one nucleus and one 
mitochondrion. But for clinical samples there will most likely be a mix of several 
parasite stages. For symptomatic P. falciparum infections microscopy mainly detects 
ring-stage parasites, however, there will often also be a low density of the other stages 
merozoites, trophozoites, schizonts and gametocytes which PCR will detect. For 
instance, molecular studies have shown that most individuals with asexual parasites 
have as well submicroscopic gametocyte carriage [128]. In addition, the definition p/µl 
give an impression that the results reflect the level of live parasites, while PCR results 
might also present residual DNA (further discussed in sections 6.2.1 and 6.2.4). In 
section 6.2.3-5 some of the results given in copies/rxn, are as well presented in p/µl for 
better understanding of quantity. The conversion is calculated by first dividing the 
number of copies/rxn with 2 due to the use of 2 µl template, than secondly dividing the 
number with 20 as one mitochondrion have 20 copies of the mitochondrial genome, 
giving an approximate quantity of p/µl, although not reflecting possible target variance 
due to different parasite stages or residual DNA.                                     
 
6.2 Assessment and application of developed PCR assays 
 
6.2.1 Assessment of conventional genus- and species-specific PCR (Paper I) 
The novel genus-specific single-step cytb PCR, and the modified species-specific 18S 
PCR, were assessed using a Norwegian clinical material consisting of 135 samples of 
suspected imported malaria. The patients (N=132) had been diagnosed with malaria in 
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26 cases by routine microscopy. Since PCR was reported to be more sensitive and 
specific than microscopy, we decided to evaluate a malaria positive sample as a 
consensus of all the method results. At least two of the methods were needed to detect 
the same result to conclude true positives/negatives. The consensus revealed 28 true 
malaria positives and 107 negatives. The assessment of the developed PCR assays 
showed that these methods were more sensitive and specific than microscopy. Seven 
samples (six patients) had discordant results between the different methods. 
Microscopy overlooked one P. malariae and one P. vivax primary infections detected 
by PCR. Typical clinical malaria cases where PCR is more sensitive than microscopy 
are early (primary or recurrent) infections as well as non-falciparum infections.  
 
P. malariae infections almost always have low parasitaemia, and can therefore be 
challenging to detect. The low parasitaemia is due to several factors as 72 hour 
erythrocyte cycle, low number of merozoites per ruptured schizont, on average eight, 
and preference for older erythrocytes [21, 129]. Although individuals with a P. 
malariae infection might experience symptomatic malaria characteristics as periodic 
chills and fever patterns, many of the P. malariae cases have the potential to go 
several months or even years without knowing their parasitic status, contributing to 
sustaining a worldwide distribution of P. malariae [5, 21]. However, a portion of the 
P. malariae cases end up in mixed infections [22, 23], and are therefore treated as a 
consequence of routine diagnostics detecting P. falciparum/P. vivax infections.  
 
The P. vivax infection overlooked by microscopy was positive two days later, and the 
patient was diagnosed with severe malaria and treated. That PCR detected the primary 
sample may indicate low parasitaemia due to early infection. PCR is reported to detect 
malaria on average 3.5 days prior to the ability of microscopy to detect the infection 
[103]. The species interpretation for this sample was inconclusive by microscopy. 
Since the patient had been in contact with macaques on a trip to New Guinea, P. 
knowlesi was suspected, but neither P. falciparum nor P. vivax was excluded as the 
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causing species. P. knowlesi is challenging to diagnose by microscopy. Firstly, low 
practical experience due to the rarity of P. knowlesi has to be expected. Secondly, P. 
knowlesi share the similar receptor affinities as P. vivax, and have a preference for 
reticulocytes. Early trophozoites morphologically resemble those of P. falciparum, and 
P. knowlesi have the ability to achieve high parasitaemia due to a 24 hour erythrocyte 
cycle producing up to 16 merozoites per schizont. Mature trophozoites, schizonts and 
gametocytes of P. knowlesi, are morphological similar to those of P. malariae [129, 
130]. Before PCR and sequencing discovered the fifth human Plasmodium species in 
studies from Malaysia, P. knowlesi infections were believed to have been 
misinterpreted as P. malariae [2]. Within four weeks later the same patient was 
admitted with recurrent malaria still with inconclusive diagnosis of species by 
microscopy. As mentioned P. vivax and P. ovale have the ability to go into a dormant 
stage in the liver, which can cause recurrent infection (relapse) weeks later if not given 
hypnozoite-eradicating treatment.  
 
Next discordant results found in Paper I; two PCR confirmed single non-falciparum 
infections (one P. ovale and one P. vivax) were over-diagnosed as double infections 
with P. falciparum by microscopy. The two cases were reported to have at least 1% 
parasitaemia. With high parasitaemia, P. falciparum is suspected for a good reason; 
the species has no age preference for the red blood cells, and produces as much as ~20-
30 merozoites per schizont in a 48 hour erythrocyte cycle. In comparison P. vivax has 
a 48 hour erythrocyte cycle producing 12-24 merozoites per schizont, and P. ovale has 
a ~48-50 hour cycle producing 6-14 merozoites, both with preference to reticulocytes 
[5, 129]. If we look at the real-time SYBR PCR results performed on the Norwegian 
material (Paper III), we found that on average the Ct value for P. falciparum infections 
was 19 (N=17), for P. vivax 20 (N=8), and for P. ovale 22 (N=3). This can be expected 
based on the different species’ life-cycle ability to induce high parasitaemia. However, 
individual factors also affect the level of parasitaemia. The Norwegian material is a 




The last discordant result to be discussed is the recurrent (recrudescence) P. 
falciparum case, positive by both microscopy and the cytb PCR. Microscopy detected 
one single ring-stage parasite, while among the PCR methods applied only the cytb 
PCR detected the infection. We argued in Paper I that the reason why the 18S PCR 
assays did not detect the infection, could be due to the lower copy number of target 
sequence. Our theory was that since the patient had been diagnosed with P. falciparum 
two weeks prior, a submicroscopic level of gametocytes may have developed in the 
meantime. Maturation of P. falciparum gametocytes takes 7-10 days [131]. The high 
copy number of the mitochondrial genome in gametocytes, about 16-32 times higher 
than an 18S target [72-74], could give an explanation to why the 18S PCR assays 
failed to detect when the cytb PCR did not. The theory of cytb PCR detection of 
submicroscopic gametocytaemia is plausible. Mature gametocytes in the blood stream 
do not cause clinical symptoms in the human host. Neither the immune system, nor 
antimalarial drugs expect primaquine, have an effect on the gametocytes, hence they 
can circulate fairly undisturbed in the blood post-treatment, awaiting transmission [41, 
100, 102]. Why the immune system does not directly attack the gametocytes is a 
mystery [132], although a rapid asexual parasite clearance by an effective immune and 
antimalarial drug response may have some indirect gametocidal effect on the level of 
mature gametocytes and their longevity [133]. Of course, we cannot rule out that the 
DNA detected was from parasite residuals rather than live parasites. The residuals can 
be sequestered in organs like the spleen and liver. It is reported that a macrophage eats 
up an infected RBC within 30 min [134], and that the phagocytic system has the 
potential to dispose up to 40-80% of the total RBC mass in a few days [135], but 
accumulated macrophages/parasite residuals in organs might take longer time to be 
cleared from the body.    
 
This thorough discussion regarding the discordant results found in Paper I is meant to 
emphasize the challenges routine microscopy encounters in diagnosing malaria, 
especially in determining the species. PCR has the ability to give more definitive 
answers, and should be recognized as a gold standard for detecting malaria. But PCR 
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methodology has its weaknesses; PCR results can obscure the diagnosing of cause of 
fever due to the portion of possible asymptomatic malaria detected by PCR. One thing 
is to interpret PCR results from returned travellers, another is to interpret the scale of 
parasitaemias found in endemic areas where premunition exists. In general, PCR is a 
too slow method for point-of-care regarding severe malaria cases. However, PCR can 
provide useful confirmation of true positives and species determination preventing 
misdiagnosis and subsequently mistreatment of malaria cases, as well as support 
education on practical microscopy skills.                                             
 
6.2.2 Application of conventional genus- and species-specific PCR (Paper II) 
Due to its high sensitivity and specificity the conventional genus-specific cytb PCR 
(Paper I) was chosen as gold standard for determination of the malaria prevalence 
among samples collected in the large multicentre study investigating causes of acute 
undifferentiated fever in India. In literature from India at the time of study and 
publication, there were to our knowledge no previous hospital based malaria 
prevalence studies using PCR from the relevant study areas. Therefore, it was difficult 
to predict malaria PCR prevalence from the study sites. Studies reporting malaria 
prevalence by microscopy among hospital fever patients could be potential misleading 
due to the questionable accuracy of microscopy. However, microscopy prevalence 
might give a good indication of clinical symptomatic malaria in endemic areas. Blood 
parasite levels as low as 50 p/µl can induce symptoms depending on immunity [136]. 
Microscopy has lowest detection limit of 4-20 p/µl under optimal conditions, but in 
field settings the limit is 50-100 p/µl [137].  
 
Since this was a hospital based study, the malaria prevalence given by PCR is not a 
measurement of the prevalence in the community/site. The study investigated the 
cause of acute undifferentiated fever, and PCR detected a high portion of 
submicroscopic malaria. Therefore the PCR prevalence might give an indication of 
what level of malaria burden is in the community, and not only the level of hospital 
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based clinical malaria. The PCR results showed high malaria prevalence in all the 
seven sites, in total 19% (268/1412), and apart from Oddanchatram (South India) with 
a prevalence of 6%, the six other sites had as high as 16% to 35% prevalence. The 
proportion of asymptomatic malaria among these numbers is unknown, but suspected 
to be fairly high because of the level of undetected malaria by microscopy and RDT. 
The level of submicroscopic malaria was as high as 71%. Potential bias to the high 
PCR prevalence might be contamination; however all genus-specific PCR results with 
discordancy with either microscopy or RDT were re-tested from the DNA extraction 
step. While potential bias to the distribution of malaria across the sites might be factors 
as patients having contracted malaria in another area than where they were 
hospitalised, and a selective inclusion of patients and samples in the favour of 
clinically suspected malaria. In addition, the differences between the hospitals in bed 
capacity, and enrolment of patients/samples to the study, may obscure the results. In 
epidemiological studies it’s common to adjust for missing patients/samples in regards 
to what was expected to be enrolled based on sample size calculations. This was not 
done in this study, and these factors may be included as potential bias to the presented 
distribution of malaria across the sites.  
In regards to distribution of asymptomatic malaria, the proportion might be high in 
endemic regions due to premunition. But level of gametocytaemias is reported to be 
increased in areas of low transmission intensity [99, 105, 138, 139]. A large 
microscopy based study from India investigating the prevalence of P. falciparum 
gametocytaemia from several site all over India reported highest prevalence in West 
India [140]. Ratnagiri (West India) had the highest prevalence in our study.  
 
India has historically been considered as a P. vivax dominating country, however the 
last decades there has been a shift in species distribution towards P. falciparum, which 
is suspected being attributed to chloroquine resistance in P. falciparum [141, 142]. Our 
study found 46% single P. falciparum versus 38% single P. vivax infections. 
Predominance of P. falciparum is expected among hospitalized malaria patients who 
are more prone to have severe disease, although 71% of the PCR positives were 
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submicroscopic malaria. The species results from routine microscopy showed a slight 
tendency to misdiagnose P.falciparum infections as P. vivax, while diagnosing P. 
vivax had a high specificity. Therefore, it cannot be ruled out that prehistory of 
predominating P. vivax areas affect the judgement of species determination, pointing 
out the importance of including PCR as quality assurance of malaria routine 
diagnostics. PCR also identified 11 P. malariae infections, which were not detected by 
microscopy. P. malariae infections are almost always in low parasite density, and 
consequently difficult for less sensitive methods to detect. PCR is a good tool to give 
awareness of the distribution for also the more neglected species [23, 143].  
 
The performance of the RDT in this study showed an unexpected low sensitivity, 
detecting only 24% (65/268) of the PCR positive malaria samples, but a high 
specificity of 99% (1129/1139). Studies comparing microscopy and RDT show 
discordant results, some find RDT more sensitive detecting malaria than microscopy, 
others find the opposite result [47, 48, 144-146]. According to Wongsrichanalai et al. 
the sensitivity of RDT can be as low as 5-15 p/µl [137], but the WHO’s large 
evaluation of RDTs found that the different commercial RDTs differ widely in 
sensitivity and specificity [46]. Our study’s RDT ParaHIT-Total device detects 200 P. 
falciparum p/µl with a detection score of 85% [46]. Since the conventional cytb PCR 
detects 0.5 p/µl with 97% (29/30) sensitivity, the low detection rate of the RDT was 
not so unexpected after all.  
The application of stored frozen EDTA blood as material is a possible bias to the low 
RDT sensitivity. Furthermore, the device has two regions, one detecting P. falciparum 
specific HRP2, and one detecting aldolase antigen of pan-malaria species. The 
sensitivity/specificity of the two regions is independent of each other. It seems like the 
‘Pf’ region was less sensitive than the ‘pan’ region, and that the ‘pan’ was less specific 
than the ‘Pf’ region; among the RDT negatives >50% were PCR positive for P. 
falciparum, while among RDT positives seven P. falciparum infections were 
misidentified as non-falciparum.               
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One of the conclusions in Paper II was that patients with low parasitaemia might serve 
as a reservoir for transmission rather that suffering from clinical malaria, pointing out 
the need for quantitative PCR malaria results. The 71% detection of submicroscopic 
malaria was not expected, but emphasises the necessity to further increase our 
awareness towards low-level parasitaemia and asymptomatic malaria. The portion of 
asymptomatic malaria was unknown in this study, and obscured the interpretation of 
the PCR results regarding diagnosing possible alternative causes of fever. We asked 
ourselves the question if q-PCR malaria results could have contributed to a higher 
level of knowledge around the boundary between clinical cases and asymptomatic 
malaria.                               
 
6.2.3 Assessment of cytb SYBR and TaqMan real-time PCR assays (Paper III) 
The conventional cytb PCR was successfully converted to real-time applying both 
SYBR Green and TaqMan probe. The Norwegian clinical material (33 positives and 
80 negatives) was used to assess the two real-time assays. Two out of the previous 
positives from 2013 were negative by the real-time assays; the recrudescent P. 
falciparum sample, and the microscopy overlooked P. malariae sample. We argued in 
Paper III that the lower sensitivities by the real-time assays were due to degradation of 
long termed frozen DNA, as indicated by conventional cytb PCR reanalysis of stored 
samples (Figure 3 in Paper III). However, the conventional PCR still detected the P. 
malariae sample, which can be due to the difference of five cycles in the PCR 
programs. The conventional PCR program has 50 contra 45 cycles in the real-time 
PCR program. Although we cannot rule out that the cytb real-time assays have slightly 
lower sensitivity towards detecting P. malariae infections than its conventional 
counterpart. To resolve this ambiguity a larger collection of P. malariae infections 
would have been needed. Otherwise, regarding the possible degraded DNA, the cytb 





Applying SYBR, a longer amplicon can be beneficial. In contrast to probes, which 
release only a single fluorophore for each amplicon, SYBR will with longer amplicons 
generate a stronger signal increasing the sensitivity as more dye is incorporated [85]. 
The cytb SYBR assay (amplicon 220 bp) seemed to have an advantage in sensitivity 
compared to using probe in this study as shown in Paper III. Furthermore, since SYBR 
binds unspecifically to all double-stranded DNA, it is important to have a high PCR 
efficiency so that the concentration of specific amplified DNA outshines the unspecific 
binding of SYBR [83]. The specificity of the SYBR assay in Paper III was 100%. 
Surprisingly, the probe assay showed one unspecific binding (Ct value 41) when 
assessing 80 negatives from the Norwegian material. Overall in Paper III the SYBR 
assay was favoured over using probe. 
 
By applying exclusively P. falciparum ring-stage reference material, the cytb real-time 
assays were compared in sensitivity with five other relevant real-time PCR methods. 
The conventional cytb PCR had shown a very high sensitivity, submicroscopic level 
above 70% [48, 115]. However, the amplicon length (220 bp) is on the upper limit of 
successful conversion to real-time PCR. To ensure that our optimized cytb real-time 
assays could compete with other malaria real-time PCR methods reported to be ultra-
sensitive, and to investigate the effect of platform and amplification target, five 
relevant assays were included in a sensitivity assessment (Table 3) [51, 75, 76, 91]. 
The methods were executed carefully according to their publications. To compare the 
assays, three parameters were chosen as common denominators for all the methods; 
master mix kit, reaction volume, and volume of template. Commercial master mix kits 
differ slightly in functionality, and are often suited to the different brands of real-time 
machines. The master mix kits used in Paper III were suited for real-time machine by 
Applied. The reaction volume chosen was 25 µl as used for the conventional cytb PCR 
in Paper I and II. Commonly applied reaction volume is 10-50 µl. The volume of 
template was chosen to be 2 µl, as previously used for the conventional cytb PCR. 




The five included methods performed applicable even with the three fixed parameters. 
Only two of the methods had a slighter lower E-value than reported, but this could be 
due to the limitation of the reference material severing as standard curve. The 
reference material gave only four dilutions (2000-2 µl). A broader range in the dilution 
series could have provided more accurate E-values. Applying a customized plasmid is 
optimal, but expensive. We cannot rule out that the included methods were negatively 
influenced by applying the fixed parameters. However, a good robust PCR method 
should be applicable under variable conditions, and adapt to different real-time PCR 
machines and routine environments. Overall, the methods performed as expected in 
line with what was reported from their publications. The choice of amplification target 
appeared to have an impact on sensitivity, with 18S as the weakest target and possibly 
varATS as the strongest. Other factors such as amplicon length, binding-affinity of the 
primers, and stability of target sequence, might also have an influence on the 
sensitivity of the PCR. In a clinical setting all the assays will be sufficient. It is merely 
the detection of low-level parasitaemia that separates these highly sensitive PCR 
assays.   
 
A dilemma in Paper III was the concern around setting a cut-off for positivity. Since 
primers in negative samples have a tendency to bind unspecific during a PCR program 
with many cycles, it is common to set a cut-off to avoid the risk of presenting false 
positives. With conventional PCR the end product is presented on a gel, and unspecific 
products can be revealed by observing incorrect sized bands. A probe will bind as a 
third oligo and therefore increase specificity greatly, but still unspecific binding and 
primer-diming can occur, which may be difficult to distinguish from true positives 
without sequencing the product, especially when the cycle number is high. The 
sensitivity for SYBR is in principle lower than for probe assays due to the unspecific 
binding to all double-stranded DNA. However, with SYBR you have the ability to 
perform MCA which is a powerful tool to reveal false positives. Since the sensitivity 
comparison using the reference material showed that several of the assays detected 
target DNA for dilutions 0.1 and 0.05 µl with an average Ct value of around 40, we 
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decided that setting a Ct cut-off for positivity would restrict the detection of low-level 
parasitaemia which was our focusing in Paper III. Regarding the Tanzanian material, 
which consisted of confirmed positive samples, we cannot rule out that amplifications 
late in the PCR programs are unspecific bindings rather than true positives. For the 
two probe assays assessed, we regarded all amplifications with curve in the 
exponential phase as positives, while with the SYBR assay, we thoroughly 
investigated each melting curve, and some late cycle amplifications were interpreted as 
false positive amplifications and concluded negative. Therefore, with focus on 
detecting low-level parasitaemia, we experienced that applying SYBR was much more 
practical and beneficial than using probe.   
 
The Tanzanian material consisted of 111 P. falciparum positive DNA samples 
confirmed by the conventional cytb PCR and the species-specific 18S PCR/sequencing 
in 2013 [48, 61]. The DNA had been long term stored on -80°C, but moved to -20°C 
during the present study (Paper III). Possible degradation of the stored DNA was 
suspected. Analysed by four PCR methods, eight samples of low parasitaemia were no 
longer reproducibly positive, but only one sample had none of the parallels detected by 
any of the methods. A positive sample was defined by at least two out of three 
parallels positive. DNA samples are regarded as a fairly stable material if kept in a 
freezer, and are often used in methodology assessments [147], although, it has been 
debated if freezing and thawing of samples can have a degrading effect on the DNA 
[148]. DNA degradation will not be notable for samples with a high amount of target 
sequences, but for samples with only a few copies of target, degradation may have an 
impact, and the samples will be positive in a randomly/non-consistently detection 
trend depending on the actual amount of target in the template (2 µl). Some samples 
might also have been more prone to degradation than others due to a varied number of 




Because of the degraded DNA the Tanzanian material could be applied as a sensitivity 
assessment of the three real-time PCR methods, our two cytb assays and the varATS 
assay. The results showed a broad range of parasitaemias, and the varATS method was 
slightly more sensitive in detecting the low-level parasitaemia samples than the two 
cytb PCR methods, most likely due to the different number of target copies. The var 
gene is situated on the chromosomal genome and exists in about 59 copies [76]. For 
ring-stage parasites, and possibly other asexual stages, the varATS target will be about 
three times more sensitive than cytb target based on copies. Whereas with the 
gametocytes the mitochondrial genome may be in as much as 160 copies, and then the 
cytb target will be at least twice as sensitive as the varATS target. Because many of 
the children in the Tanzanian material had been given antimalarial drugs within four 
weeks prior to admission (62%), gametocytaemia was suspected in the low-level 
parasitaemia samples. However, since the varATS assay showed highest sensitivity, 
we speculated in Paper III that many of the low-level parasitaemias were mostly 
asexual parasite detections, rather than gametocytaemia. Even though the patients were 
young children, we cannot rule out that malaria with low parasitaemia was due to 
innate immunity or premunition. For example low parasitaemia was associated with 
children under one year. Antibodies from mother given trough birth or breastmilk 
might give young children a protection against developing malaria from infectious 
bites [149, 150]. Furthermore, malaria superinfections are rarely seen in young and 
semi-immune children compared to older children and adults, which might be because 
young children have a high level of asexual erythrocytic parasites protecting them 
from new malaria infections [30].      
 
6.2.4 Application of cytb SYBR PCR focusing on low parasitaemia (Paper III) 
To investigate the challenges in applying DNA extracted from different materials, we 
compared the cytb SYBR PCR results using DNA from 37 patients, where blood had 
been collected and DNA extracted in two ways (EDTA whole blood/Qiagen column 
and DBS/Chelex). Among the original 74 conventional PCR positives using DNA 
extracted from EDTA blood, only 59% (44/74) were positive using DNA from DBS 
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material [48, 61]. This underlined the lower sensitivity applying DBS; none of the very 
low-level parasitaemias were expected to be detected by using DBS material. Not so 
surprisingly considering the great difference in blood volume for the two diverse 
collection methods; 200 µl EDTA blood versus 50 µl DBS blood, and as reported by 
Strøm et al. only six  punches (~25 µl blood) are being used in the Chelex extraction 
method [151]. Looking at the cytb SYBR PCR results (N=37), applying DBS is fairly 
sensitive; DBS detected down to 25 target copies/rxn, corresponding to ~ 0.5 p/µl. In 
comparison, in the q-PCR assessment (N=74) we defined low parasitaemia as ≤ 1000 
copies/rxn, and using EDTA material detected down to 1 copy/rxn, corresponding to 
0.025 p/µl. Therefore, applying DBS material is applicable for detecting clinical cases, 
but will miss cases in asymptomatic malaria research.  
 
Regarding the two Ct trends from the results EDTA versus DBS template, they showed 
a constant difference of 4-9 cycles (for 31 out of 37 samples the difference was 7-9 
cycles), which once again underline the lower sensitivity using DBS, although the 
consistent trends also show how accurate and robust PCR truly is, even applying 
stored DNA. Furthermore, looking at the results from the sensitivity assessment of the 
previously PCR positive Tanzanian field material (N=111), DNA extracted from DBS 
showed a higher stability with only a few previously positive samples being negative 
compared to several false negatives by applying whole blood DNA. This can be due to 
the fact that ion‐exchange resin Chelex solution inhibits DNA degradation by 
chelating metal ions, which otherwise may catalyze breakdown of DNA [152].  
 
Plasma may also be used for malaria real-time PCR. It is shown an association 
between high parasitaemia and severe malaria applying plasma as material. However, 
using plasma has its limitations due to general lower sensitivity than applying whole 




The conventional PCR results from Paper I and II defined PCR as superior to 
microscopy and RDT in sensitivity and specificity, and the real-time SYBR PCR 
results in Paper III showed the same. Looking at the cytb SYBR PCR results applying 
the Tanzanian P. falciparum positive material (N=74), microscopy showed a low 
sensitivity of 32% (24/74). Among the microscopy positives the sample with lowest 
number of copies/rxn by the SYBR PCR had as much as 15300 copies/rxn, 
corresponding to 380 p/µl. The RDT had higher sensitivity than microscopy detecting 
53% (35/66) positives. Among the RDT positives four of the samples were defined in 
Paper III as low parasitaemia, and the samples with lowest number of copies/rxn had 
25 copies, corresponding to 0.6 p/µl. For 31 RDT positives the parasitaemia was ≥ 95 
p/µl. Among the RDT negatives (N=31) all of them were regarded as low 
parasitaemias (≤ 15 p/µl).  
 
These three diagnostic methods, microscopy, RDT and PCR, have very distinct 
approaches to identifying malaria. Some of the variance in sensitivity and specificity 
can be explained having knowledge and understanding about what the methods 
actually detect. Live parasites are directly visualized by microscopy, and therefore this 
method will mostly identify symptomatic malaria infections of high parasitaemia. 
Microscopy has the potential to detect gametocytes [140], but this parasite stage is for 
an unknown reason always in a low density in the blood [132]. RDT detects antigens, 
which are proteins produced by live parasites, but can be retained in circulation after 
parasite clearance. Because of this, RDT is reported to potentially be positive as long 
as up to two months post-treatment. A systematic review of publications on persistent 
positivity of RDTs concluded that for HPR2 antigen 50% of the tests were still 
positive by day 15, and 5% positive after 36 days. For the Plasmodium lactate 
dehydrogenase antigen, 50% were positive by day 2, and 5% after 10 days. In young 
children 50% of the tests were still positive by day 11, and 5% after 31 days, while, for 
adults there was a persistent positivity in 50% by day 4, and 5% after 19 days [155]. 
The review paper did not describe RDTs using aldolase, such as the RDT applied in 
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Paper II. False RDT positives can also occur, it has been reported that false positives 
are associated with patients expressing a high level of rheumatoid factor [156].  
 
PCR detects target DNA derived from infected RBCs, free merozoites, and parasite 
residuals sequestered in immune cells or free in the blood circulation. This means that 
PCR has the potential to detect low density of malaria DNA produced by premunition, 
early (primary or recurrent) infections, non-falciparum infections, dormant stages, 
gametocytes, persistent clones, and destroyed parasites. In endemic areas residents can 
have repeated and low-level asymptomatic parasitaemia in the blood, controlled by 
acquired immunity, protecting them from further infections (premunition). The portion 
of low-level parasitaemia detected by real-time PCR caused by premunition is 
unknown, but immunity and prevalence of asymptomatic malaria in an area is related 
to level of transmission. Gametocytes can circulate for weeks and months post-
treatment, while untreated chronic malaria infections may also persist at low densities 
for months, even years [24, 101]. There is also evidence from studies that asexual 
blood stage P. falciparum parasites may become temporarily inert or dormant 
subsequently surviving therapeutic concentrations of anti-malarial drugs, and that 
these low density dormant forms can be detected by PCR, but not microscopy [136].   
 
It is unknown for how long DNA residuals will circulate in the blood after parasite 
clearance, but it is probably depends on level of parasitaemia and the effectiveness of 
drug-treatment and immune response. The spleen has a major function in removing 
malaria parasites from the circulation. A phenomenon called pitting involves the 
spleen removing intra-erythrocytic parasite particles without destroying the red blood 
cell and sending the cells back out in circulation [157]. In an endemic setting collected 
blood will represent a dynamic possibility of PCR positivity due to the many factors 




6.2.5 Assessment and application of q-PCR (Paper III) 
An ideal application of malaria q-PCR would be to be able to differentiate between 
clinical symptomatic malaria and asymptomatic malaria. However, this is a dream 
scenario. Unfortunately it is not possible to define a cut-off for several reasons. 
Examples of clinical low-level parasitaemias are early and non-falciparum infections. 
Circulating gametocytes are reported to not be harmful to the host, but are responsible 
for the transmission reservoir. There has been developed real-time PCR methods 
detecting mRNA specifically produced by gametocytes, but mRNA material is 
expensive and challenging to collect and extract. Special sample tubes with RNase 
activity are needed to preserve the mRNA efficiently [64, 158]. In general malaria 
real-time DNA-based PCR technology has not come further (yet) than to show 
quantitative results; one can only speculate about the reasons behind low-level 
parasitaemia. It can also be debated if all asymptomatic malaria should be treated in 
regards to premunition and further spread of drug resistance.       
 
One of our objectives in Paper III was to present an alternative and relevant 
application of q-PCR data investigating the association between low parasitaemia and 
clinical and demographic factors (N=74). Since the samples had been collected in 
order to perform malaria PCR, but for a different purpose and application (Strøm et al. 
investigating challenges in diagnosing paediatric malaria [48]), the collection may not 
have been optimal for this q-PCR approach; small sample size, limited age interval 
(children ≤ 5 years), as well as few clinical parameters. Another limitation to the q-
PCR assessment was the possible degradation of the stored DNA, which resulted in 
several of the previously PCR confirmed positive samples were negative by present 
cytb SYBR PCR. Regarding the patient data, we decided that it was correct to also 
include q-PCR results with value zero in the assessment.  
 
The association between the q-PCR results and included patient data were evaluated 
applying cross tabulation (univariate) and multiple logistic regression (multivariate) 
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analysis. We decided to categorize the q-PCR values into the categories ≤ 1000 
copies/rxn (N=37, range 0-953, Ct value ≥ 27) defined as low parasitaemia, and > 1000 
copies/rxn (N=37, range 3769-1.6x107, Ct value ≤ 24) defined as high parasitaemia. 
This categorization was based on a thorough evaluation of the different frequency 
data, for example it was a gap of three cycles between low and high parasitaemia 
distributions. The median value was 2360 copies/rxn (N=74).  A 1000 copies/rxn is a 
considerable low limit corresponding to only 25 p/µl. However, we wanted the low 
parasitaemia to represent submicroscopic malaria; the range of high parasitaemia 
started at 3770 copies/rxn, corresponding to ~100 p/µl, which under optimal 
conditions an experienced microscopist would be able to detect. Except for two 
samples, all of the high parasitaemia samples had more than 10 000 copies/rxn 
corresponding to > 250 p/µl. In this study microscopy had the most sensitive detection 
at Ct value 23 (15300 copies/rxn, 380 p/µl).  
 
Both the univariate and multivariate analysis found a significant correlation between 
age ≤ 12 months and low parasitaemia. As mentioned, antibodies from mother and in 
breastmilk may give some protection in the children’s first months of life [149, 150], 
which may be an explanation to this association. Furthermore, in the univariate, but 
not in the multivariate analysis, low parasitaemia was significantly associated with 
death in hospital. Severe P. falciparum infection kills hundreds of thousands people 
every year, especially young children. Malaria is regarded as one of the most 
prominent infectious diseases worldwide, with highest burden in Africa, and high 
malaria parasitaemia is known to be a risk factor for death. In our material (N=74) 15 
of the children died in hospital, and 11 of these were in the category low parasitaemia. 
The explanation to the significance found in the univariate analysis can be all from 
over-diagnosed malaria, to missed opportunity of early malaria treatment, or to an 
unknown effect of a recent malaria episode. Regarding acute undifferentiated febrile 
illness in malaria endemic areas, the awareness towards malaria being the cause of 
fever is high, and may obscure the diagnosis of other severe blood stream infections. 
Low parasitaemia was associated with the children being less frequently given the 
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diagnosis malaria, and less frequently given antimalarial treatment in hospital. 
Furthermore, the low density DNA detected by PCR could stem from a recently 
treated malaria episode; young children are reported to have an increased risk of death 
due to anaemia in the subsequently months after having been hospitalized with malaria 
[159, 160]. A malaria infection causes a great loss of red blood cells in the host. In 
malaria endemic areas iron deficiency is suspected to give young children a natural 
protection against malaria, but subsequently may cause macrophages to retain their 
iron, which potentially can have an effect on the behaviour of macrophage-tropic and 
iron-requiring pathogens such as non-typhoidal Salmonella, tuberculosis and HIV-1 
[30].  
 
6.2.6 Other applications of malaria q-PCR 
The WHO has identified 21 countries that can be able to eliminate malaria by 2020 
[10]. To survey malaria control and elimination strategies, applying ultra-sensitive and 
specific screening tools such as the cytb SYBR q-PCR method are of importance. 
Ways of controlling and eliminating malaria can be using LLITNs, IRS, or mass drug 
administration (MDA), where all members of a defined population are given anti-
malarial treatment. There are different variations of MDA. The treatment can target a 
small high-risk area such as a household, village, or hot-spot, or target high-risk 
populations such as pregnant women or infants/children. In mass/focal screening and 
treatment programs (M/FSAT), all members of a defined population are tested for 
malaria and those with a positive result, and/or members in close proximity to the 
positive case, are treated [161]. The effect and long-term results of the different 
elimination strategies are necessary to follow up by using sensitive and specific 
methods detecting all levels of parasitaemias. Other settings were PCR-based detection 
of low-level parasitaemia are of importance, are malaria screening and surveillance of 
blood-bank and donor-transplantation material [162], persistent Plasmodium clones 
[163], clinical vaccine trials [164], drug resistant trends [165], and multiplicity of 




PCR is an important tool in malaria diagnostics, epidemiology, and surveillance 
research. The technology is highly sensitive and specific, and is superior to 
microscopy and RTD. However, there is still need to further improve the performance 
of malaria PCR techniques. The different PCR methods show variances in sensitivity 
and specificity, as well as in practicality and application. The choice of amplification 
target has an impact on sensitivity. The previously standard 18S target showed low 
sensitivity compared to new relevant targets. The chromosomal P. falciparum-specific 
varATS target showed a very high sensitivity, as did the mitochondrial genus-specific 
cytb target, which is particularly sensitive towards gametocytes. The high portion of 
submicroscopic cases found in endemic areas may be asymptomatic carriage of 
malaria, and can obscure the diagnosis of other severe blood stream infections causing 
acute undifferentiated febrile illness.  
 
Real-time technology has several advantages over conventional PCR, although it is a 
more expensive method. Quantitative results give valuable information, and increases 
awareness and knowledge about the level of parasitaemia, especially submicroscopic 
malaria. It is not possible to set a cut-off between clinical and asymptomatic cases 
based on only q-PCR results. By testing several real-time PCR assays, applying both 
SYBR and TaqMan methodology, it was advantageous to use an intercalating 
fluorescence dye suitable for MCA rather than labelled hydrolysis probes. MCA 
helped to distinguish between true low-level malaria positives and unspecific binding 
or primer-dimers. The highly sensitive, specific and user-friendly cytb SYBR q-PCR 
developed in this study can be a useful tool in epidemiological and surveillance 
research, as well as for clinical malaria diagnostics. The method is genus-specific, 
which is an advantage in large screening projects. Among ambiguous samples, and in 
settings where species-specific PCR fails to detect low-level parasitaemia, 
confirmation and species identification by sequencing of the genus-specific real-time 
PCR products can be used as a contingency.           
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8. FURTHER RECOMMENDATIONS 
● Implement PCR as a quality assurance of malaria routine diagnostics. 
● Include q-PCR in epidemiological studies. 
● Stored DNA should be applied with caution, and DNA extracted from whole blood 
is preferable. Further investigation of material for the cytb SYBR PCR method is 
direct PCR methodology [167], and pooling of template [168].   
● PCR should be applied to give awareness to the neglected P. malariae species, 
which is often missed by microscopy.    
● Investigate further if the SNPs found in the cytb amplicon are universal in different 
strains of the species.  
● The alternative q-PCR approach presented in this study should be applied in larger, 
prospective studies employing comprehensive diagnostics for the major relevant 
differential diagnosis of acute undifferentiated febrile illness, and include tuberculosis, 
HIV and iron status.  
● An unknown portion of the low parasitaemias is probably due to gametocytes, and 
methods detecting mRNA specifically produced by gametocytes could be relevant to 
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A novel, single-amplification PCR targeting
mitochondrial genome highly sensitive and
specific in diagnosing malaria among returned
travellers in Bergen, Norway
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Abstract
Background: Nested PCR is a commonly used technique in diagnosis of malaria owing to its high sensitivity and
specificity. However, it is time-consuming, open to considerable risk of contamination and has low cost-efficiency.
Using amplification targets presented in multiple copies, such as rRNA 18S, or mitochondrial targets with an even
higher copy number, might increase sensitivity.
Methods: The sensitivity and specificity of two newly designed Plasmodium genus-specific single-round
amplification PCR programmes, based on previously published primers targeting 18S and mitochondrial genome,
were compared with a widely used nested 18S PCR. Analyses of dilution series from Plasmodium falciparum
reference material were performed, as well as retrospective analyses of 135 blood samples, evaluated by routine
microscopy, from 132 fever patients with potential imported malaria. Sequencing of the 220 bp mitochondrial PCR
products was performed.
Results: At the threshold dilution 0.5 parasites/μl, the sensitivity of the mitochondrial PCR was 97% (29/30 parallels),
that of the single-round 18S PCR 93% and the reference nested 18S PCR 87%. All three assays detected as low as
0.05 p/μl, though not consistently. In the patient cohort, malaria was diagnosed in 21% (28/135) samples, defined
as positive by at least two methods. Both single-round amplification assays identified all malaria positives diagnosed
by nested PCR that had sensitivity of 96% (27/28). The mitochondrial PCR detected one additional sample, also
positive by microscopy, and was the only method with 100% sensitivity (28/28). The sensitivity and specificity of the
mitochondrial PCR were statistically non-inferior to that of the reference nested PCR. Microscopy missed two
infections detected by all PCR assays. Sequencing of the genus-specific mitochondrial PCR products revealed
different single nucleotide polymorphisms which allowed species identification of the 28 sequences with following
distribution; 20 P. falciparum, six Plasmodium vivax, one Plasmodium ovale and one Plasmodium malariae.
Conclusions: In this study, design of PCR programmes with suitable parameters and optimization resulted in
simpler and faster single-round amplification assays. Both sensitivity and specificity of the novel mitochondrial PCR
was 100% and proved non-inferior to that of the reference nested PCR. Sequencing of genus-specific mitochondrial
PCR products could be used for species determination.
Keywords: Malaria, Diagnostics, PCR, Amplification, Sequencing, Mitochondrial DNA, 18S, Sensitivity, Gametocytes,
Returned travellers
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Background
More than three billion people world-wide are exposed
to malaria, resulting in an estimated 200 million malaria
cases and 1.2 million deaths in 2010 [1]. Routine diagno-
sis is usually done by microscopy and/or rapid diagnostic
antigen detection tests, and may be influenced by factors
such as the technologists’ level of experience, and equip-
ment quality [2,3]. Several molecular techniques have
been developed, including polymerase chain reaction
(PCR), with the aim of increasing the sensitivity and
specificity [4,5].
Malaria PCR was first introduced in 1990 [6], and sub-
sequently has evolved with new amplification methods
such as Real-Time PCR and loop-mediated isothermal
amplification (LAMP) [7,8]. Both the latter methods
have advantages over conventional PCR in turnaround
time and in practical use as the detection step is incor-
porated into the amplification step. Nevertheless, the
nested PCR originally described by Snounou et al. in
1993 [9] and improved in 1999 [10], remains commonly
used and often regarded as a gold standard/reference
method. Nested PCR exhibits high sensitivity and specifi-
city due to two amplification steps, but is time-consuming,
open to considerable risk of contamination and has low
cost-efficiency [11-16].
High sensitivity has also been achieved by using
amplification targets existing in multiple copies in the
Plasmodium genome [17]. A common target is the con-
served small subunit ribosomal RNA 18S locus [9,18,19]
which in the Plasmodium falciparum chromosomal gen-
ome exists in five to eight copies depending on the
strain [20]. Snounou et al. [9] reported a sensitivity of
one to 10 parasites per microlitre (p/μl) of blood using
nested PCR with 18S as the target gene. Polley et al. [21]
reported a sensitivity of 5 p/μl introducing a LAMP
method using an amplification target on the 6 kb mito-
chondrial genome. In comparison, a LAMP assay employ-
ing primers targeting 18S had a sensitivity limited to
approximately 100 copies of the gene for P. falciparum
[19]. Early ring stage P. falciparum parasites typically have
one mitochondrial organelle, which contains about 20
copies of the 6 kb genome, while mature gametocytes have
as much as four to eight mitochondrial organelles [22,23].
Although one would expect assays using mitochondrial
targets to show higher sensitivity given the higher copy
number, PCR-based methods targeting 18S are commonly
the methods of choice [17,24].
The main aim of this study was to design practical
single-round amplification Plasmodium genus-specific
PCR assays, based on previously described primers tar-
geting the 18S locus [9] and the mitochondrial genome
[21], with sensitivity and specificity non-inferior to
nested PCR [10]. Comparisons were performed using
reference material and samples from a cohort of fever
patients with potential imported malaria in Bergen,
Norway.
Methods
Patient materials, positive controls and reference sample
The patient material used in this study had been col-
lected between 2006 and 2011 at Haukeland University
Hospital, Bergen, Norway. It included 135 whole blood
samples from a cohort of 132 fever patients with poten-
tial imported primary or recurrent malaria. As part of
the routine work-up these samples had been previously
analysed for malaria parasites on Giemsa-stained, thin
and thick slides by experienced microscopists. The rou-
tine microscopy results and clinical information were
collected retrospectively from patient files.
External DNA controls extracted from P. falciparum,
Plasmodium vivax, Plasmodium ovale and Plasmodium
malariae supplied by the Centre for Tropical Diseases,
McGill University (Quebec, Canada) [25] were used in
the validation of the genus-/ and species-specific PCR
assays in the study. In addition, an external reference
sample of P. falciparum, US 04 F Nigeria XII (World
Health Organization, Geneva, Switzerland), was used to
examine the sensitivity of the genus-specific PCR assays.
P. falciparum was the only cultivated species accessible.
The reference material contained exclusively ring stage
parasites in a concentration of 200 p/μl. Employing tem-
plate from the reference material together with extracted
DNA from blood of a Norwegian malaria negative vol-
unteer, a combination of two 10-folds dilutions series
were prepared giving the following series: 10 p/μl, 5 p/
μl, 1 p/μl, 0.5 p/μl, 0.1 p/μl, 0.05 p/μl, and 0.001 p/μl.
From all blood samples DNA was extracted using
QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Germany)
according to the manufacturer’s instructions. Both blood
and extracted DNA material was stored at -20°C prior to
application.
PCR methods
Three PCR assays, two genus-specific and one species-
specific, were assessed in the cohort of patient samples
described above. The genus-/ and species-specific nested
18S PCR as described by Singh et al. [10] was included
as a reference method. In each PCR assay the reaction
mixtures contained 2 μl of DNA template and 12.5 μl
2X HotStarTaq Master Mix (Qiagen) at a total volume
of 25 μl. The amplifications were performed by using
GeneAmp PCR System 9700 (Applied Biosystems,
Carlsbad, CA, USA), and the PCR products were ana-
lysed by electrophoresis using 2% SeaKemW agarose gel
(Lonza, Rockland, ME, USA) with 1X GelRed™ (Biotium,
Hayward, CA, USA). Concentrations of primers and
additional MgCl2 were optimized for each assay examined
as described below.
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One genus-specific PCR assay employed primers rPLU
6 and rPLU 5 (Table 1) targeting 18S. The amplification
conditions were modified and optimized from the original
nested [9] to a single-round amplification assay with cycle
parameters as follows: step 1, 95°C for 15 min; step 2, de-
naturation at 95°C for 10 sec; step 3, annealing at 63°C for
10 sec; step 4, extension at 72°C for 75 sec; steps 2-4
repeated 50 times; and step 5, 72°C for 10 min.
The other genus-specific assay was a new single-round
amplification PCR using primers PgMt19 F3 and
PgMt19 B3 (Table 1), targeting the mitochondrial gen-
ome and previously employed in a LAMP assay [21].
The primers were analysed using Oligo v6 primer ana-
lysis software (Molecular Biology Insights, Cascade, CO,
USA), and tested with Basic Local Alignment Search
Tool (BLAST, National Center for Biotechnology Infor-
mation, Bethesda, MD, USA) before being considered
suitable for use in a conventional PCR assay. Subse-
quently, the following amplification conditions were
designed: step 1, 95°C for 15 min; step 2, denaturation at
95°C for 10 sec; step 3, annealing at 62°C for 10 sec; step
4, extension at 72°C for 15 sec; steps 2-4 repeated 50
times; and step 5, 72°C for 10 min. Reaction mixture for
both assays contained 250 nM of each primer, and add-
itionally 4 mM MgCl2 (New England BioLabs, Ipswich,
MA, USA).
The P. falciparum, P. vivax, P. ovale and P. malariae
species-specific PCR protocol was employed on all genus-
specific PCR positive samples applying primers targeting
18S previously published by Padley et al. [26]. As opposed
to the original multiplex assay, each sample was analyzed
in four separate reaction mixtures to avoid difficulties in
species interpretation due to similar product sizes. Only a
few single nucleotide polymorphisms (SNPs) distinguish
the different forward primers’ hybridization sites. In order
to avoid non-specific cross-binding between P. falciparum
and P. vivax samples, a new P. vivax forward primer
(Table 1) was designed using Oligo v6, the sequence align-
ment editor software BioEdit v7 (Tom Hall, Carlsbad, CA,
USA) and BLAST. The amplification conditions were
modified and amplification time substantially reduced
from six to two hours. The new cycling parameters were:
step 1, 95°C for 15 min; step 2, denaturation at 95°C for
10 sec; step 3, annealing at 65°C for 10 sec; step 4, exten-
sion at 72°C for 30 sec; steps 2-4 repeated 45 times; and
step 5, 72°C for 10 min. The reaction mixtures contained
additional MgCl2 which was optimized as follows: 4 mM
for P. ovale, 2 mM for P. falciparum and P. malariae, and
1 mM for P. vivax. The primer concentrations were 250
nM with an exception of 150 nM for P. ovale.
Sequencing
For quality assurance purposes, all PCR products from
genus-specific positive samples using primers PgMt19
F3&B3 (Table 1) were sequenced in both directions. The
PCR products were purified with ExoSAP-ITW (USB
Corporation, Cleveland, OH, USA) according to the
manufacturer’s instructions, prior to the following cycle
conditions being applied using GeneAmp PCR System
9700 (Applied Biosystems): step 1, 96°C for 10 sec; step
2, 62°C for 5 sec; step 3, 60°C for 4 min; steps 1-3
repeated 27 times. Each reaction mixture contained 1 μl
BigDye v1.1 (Applied Biosystems), 2 μl sequencing buffer
5X (Applied Biosystems), 0.5 μM primer, and 1 μl tem-
plate at a total volume of 10 μl. The sequences were
obtained with the ABI PRISMW 3730 DNA Analyzer
(Applied Biosystems). BioEdit v7 was used prior to se-
quence identification using BLAST.
Statistical methods
Proportions were compared applying prtest command
using Stata 11 (Stata Corp, College Station, Texas, USA),
and differences in sensitivity and specificity with 95%
confidence intervals (95% CI) were calculated. Non-
inferior of the test was considered proved if the upper
boundary of the 95% CI of the sensitivity difference was
less than a predefined delta of 5%.
Table 1 Primers applied for the amplifications and sequencing examined in this study
Primer1 Sequence Published by
rPLU 6 forward 50-tta aaa ttg cag tta aaa cg Snounou et al. [9]
rPLU 5 reverse 50-cct gtt gtt gcc tta aac ttc Snounou et al. [9]
PgMt19 F3 forward 50-tcg ctt cta acg gtg aac Polley et al. [21]
PgMt19 B3 reverse 50-aat tga tag tat cag cta tcc ata g Polley et al. [21]
Plasmodium falciparum forward 50-aac aga cgg gta gtc atg att gag Padley et al. [26]
Plasmodium vivax forward 50-gag cgt tca aag caa aca ga This study
Plasmodium ovale forward 50-ctg ttc ttt gca ttc ctt atg c Padley et al. [26]
Plasmodium malariae forward 50-cgt taa gaa taa acg cca agc g Padley et al. [26]
Species-specific reverse 50-gta tct gat cgt ctt cac tcc c Padley et al. [26]
1 The primers were obtained from Eurogentec (Seraing, Belgium).
Haanshuus et al. Malaria Journal 2013, 12:26 Page 3 of 8
http://www.malariajournal.com/content/12/1/26
Ethics
The study was approved by the Regional Committee for
Ethics in Medical Research (No.2011/942).
Results
The sensitivity of detection was examined for the three
genus-specific amplification assays; the new single-round
amplification mitochondrial PCR employing primers
PgMt19 F3&B3 [21], the modified single-round amplifi-
cation 18S PCR employing primers rPLU 6&5 [9], and
nested 18S PCR [10] as the reference method. Based on
30 parallels of the described dilution series, the 0.5 p/μl
dilution proved to be the threshold detection level for all
three assays (Figure 1). The mitochondrial PCR detected
0.5 p/μl with 97% sensitivity (29/30), while the modified
18S PCR and nested 18S PCR detected 0.5 p/μl with
93% (28/30) and 87% (26/30) sensitivity, respectively. At
the threshold detection level of 0.5 p/μl, the sensitivity
of the mitochondrial PCR, was statistically non-inferior
to that of the reference nested 18S PCR, as the upper
boundary of the 95% CI (-23.8% to 3.8%) of the sensitiv-
ity difference (10.0%) was less than the predefined delta
of 5%. Although, the sensitivity of the modified 18S PCR
also was higher than that of the reference nested 18S
PCR in absolute numbers, statistical non-inferiority
could not be proved in this sample size (sensitivity dif-
ference -6.7%, 95% CI -21.8% to 8.4%). All three assays
detected positive DNA as low as 0.05 p/μl, though not
consistently so by any method.
After having determined sensitivity of detection in
standardized material, the 135 patient samples (132
patients) were screened for the presence of malaria by
the three genus-specific PCR assays. Among these sam-
ples, 21% (28/135) were defined as malaria positive by at
least two of the methods among microscopy and the
three different genus-specific PCR assays. The new mito-
chondrial PCR was 100% sensitive detecting all 28 posi-
tives. Both the modified 18S PCR and the nested 18S
PCR detected 27 of the positives corresponding to a sen-
sitivity of 96%. Routine microscopy detected 26 of the
positives corresponding to a sensitivity of 93% (Table 2).
The mitochondrial PCR detected one positive sample
not detected by any of the two 18S PCR assays, which
was also positive by microscopy. Two positive samples
not detected by microscopy were detected by all three
PCR assays (Table 2). The sensitivity of the mitochon-
drial PCR was statistically non-inferior to that of the
reference 18S PCR, as the upper boundary of the 95% CI
(-10.4% to 3.3%) of the sensitivity difference (-3.6%) was
less than the predefined delta of 5%. Although the sensi-
tivity of the modified 18S PCR was equal to that of the
reference nested 18S PCR in absolute numbers, statis-
tical non-inferiority could not be proved in this patient
cohort (sensitivity difference 0%, 95% CI -9.7% to 9.7%).
None of the malaria-negative patients had false posi-
tive tests by any of the diagnostic methods, thus all the
tests had 100% specificity in this cohort. The specificity
of both the mitochondrial PCR and the modified 18S
PCR were statistically non-inferior to that of the refer-
ence nested 18S PCR (specificity difference 0.0%, 95% CI
0.0 to 0.0%).
The 28 malaria positive samples were all further exam-
ined by two species-specific 18S amplification assays; an
assay modified from a multiplex PCR [26], and species-
specific nested PCR assay [10] as the reference method.
The first assay, which was modified from a multiplex
into four separate reactions with a new P. vivax forward
primer, as described above, showed no cross-bindings
between the new P. vivax primer and P. falciparum posi-
tive samples (Figure 2). Previously observations showed
that the original P. vivax forward primer unspecifically
cross-bonded with P. falciparum positive samples, espe-
cially when the parasitaemia was high.
Sequencing of the genus-specific mitochondrial PCR
products was performed giving high-quality sequences
of full length. When the sequences were run through
Figure 1 Sensitivity of three different Plasmodium genus PCR protocols. A dilution series, run in 30 parallels, was prepared from a 200 p/μl
stock of Plasmodium falciparum, US 04 F Nigeria XII. The 2% agarose gel picture shows a typical parallel for each assay; new single-round
amplification mitochondrial PCR employing primers PgMt19 F3 & B3 [21] (A), modified single-round amplification 18S PCR employing primers
rPLU 6 & 5 [9] (B), and gold standard genus-specific nested 18S PCR [10] (C). The product sizes are 220 base pair (bp), 1200 bp, and 250 bp,
respectively. Lane 1 = 100 bp DNA Ladder (New England BioLabs), lane 2 = 10 p/μl, 3 = 5 p/μl, 4 = 1 p/μl, 5 = 0.5 p/μl, 6 = 0.1 p/μl, 7 = 0.05 p/μl,
8 = 0.001 p/μl, and 9 = no template. The new mitochondrial PCR had more defined bands than the modified 18S PCR, and especially the nested
18S PCR.
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BLAST the results showed two to six SNPs and one
insert/deletion which allowed species determination in
all the 28 sequences, revealing 20 P. falciparum, six
P. vivax, one P. ovale, and one P. malariae sequences
(Figure 3, Table 3). Both species-specific 18S PCR assays
identified 18 P. falciparum, six P. vivax, one P. ovale,
and one P. malariae single infections, and one double in-
fection of P. falciparum and P. malariae (Table 3). While
the routine microscopy had identified 20 P. falciparum,
three P.m vivax, and one Plasmodium knowlesi/inconclu-
sive single infections, and two samples with P. falciparum
in double infection with P. ovale and P. vivax, respectively
(Table 3).
In seven samples (six patients) the different methods
had discordant results (Table 4). Based on the combined
results from routine microscopy, all PCR assays and
sequencing, these samples were evaluated giving the
following interpretations; sequencing as a diagnostic
method missed Plasmodium malariae in a double infec-
tion of P. falciparum and P. malariae, all 18S PCR assays
(genus-/and species-specific) missed one P. falciparum
positive sample detected by both the new mitochondrial
PCR and microscopy, and routine microscopy missed one
P. malariae and one P. vivax single infection as well as
P. malariae in a double infection of P. falciparum and P.
malariae. Microscopy incorrectly evaluated two single
infections as double infections with P. falciparum, and in-
correctly evaluated a P. vivax as P. knowlesi infection
(Table 4).
Discussion
The two Plasmodium genus-specific single-round ampli-
fication PCR assays presented in this study were as
follows: a new mitochondrial PCR employing primers
PgMt19 F3&B3 [21], and a modified 18S PCR employing
primers rPLU 6&5 [9]. By designing single-round ampli-
fication assays, the cost-efficiency, turnaround time, con-
tamination risk, and the possibility of technical errors
are considerably reduced compared with the nested PCR
reference method [10]. Previously published 18S pri-
mers, rPLU3&4 [10], were also considered for single-
round amplification because of short product size
(250 bp versus 1200 bp), but discarded due to high
annealing temperatures, 71 and 75°C (contra 63 and
64°C for rPLU6&5). Snounou and Singh [9,10] reported
that the 18S primers showed reduced sensitivity in
single-round PCR amplifications, however this study
shows that single-round amplifications have the same
sensitivity and specificity as nested PCR given suitable
parameters and optimisation. The new PCR programs
were designed with a high number of cycles and high
concentration of additional magnesium chloride, so that
the sensitivity of nested PCR was maintained. Further-
more, due to the quick cycles in the designed programs
and the high annealing temperatures, also the specificity
of nested PCR was maintained despite the high number
of cycles. The results from the dilution series showed
that both the single-round amplification assays detected
a higher number of parallels with positive DNA at the
threshold dilution level of 0.5 p/μl compared to the
nested PCR reference method. In the patient material
the two single-round assays correctly identified all the
positives and negatives found by the nested PCR, with
the exception of one sample positive only by mitochon-
drial PCR and microscopy. Statistically the sensitivity of
the mitochondrial PCR was non-inferior to that of the
reference nested 18S PCR in this patient cohort as well
as in the dilution series (at the threshold 0.5p/ μl dilu-
tion). Although the sensitivity of the modified 18S PCR
could not be proven to be statistically non-inferior to
nested PCR in this limited sample size, the test was
Table 2 Genus-specific results from a cohort of 132 fever patients with potential imported malaria
Samples (n = 135) New single-round amplification
mitochondrial (PCRPgMt19 F3 & B3 [21])
Modified single-round amplification




Positive 28 27 27 26
Negative 107 108 108 109
Figure 2 No cross-binding reactions applying new Plasmodium
vivax forward primer in modified species-specific 18S PCR [26].
The original Plasmodium vivax primer from a multiplex PCR [26]
cross-bonded with Plasmodium falciparum when applied in the
modified species-specific 18S PCR [26]. The new Plasmodium vivax
(Pv) primer was cross tested against different Plasmodium falciparum
(Pf) patient samples with diverse levels of high parasitaemia. The
results showed on a 2% agarose gel. Lane 1 = 100 bp DNA Ladder,
lanes 2-6 = Five different positive Pv patient samples, lane 7 = 2% Pf,
lane 8 = 2-3% Pf, lane 9 = 7% Pf, lane 10 = 7-10% Pf, lane 11 = 10-
15% Pf, lane 12 = 20% Pf, and lane 13 = No template. The product
size of Pv is 241 bp.
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equal to or better than the nested PCR in absolute num-
bers. The specificities of both single-round amplification
assays were statistically non-inferior to that of the nested
PCR.
In Plasmodium parasites the mitochondrial genome is
presented in a higher copy number than 18S, especially
in gametocytes. While the copy number of 18S locus
varies depending on strains, and not on the stages of the
parasite since it is located on the chromosomal genome
[20], the multiple mitochondrial genome is located in
the mitochondrial organelles which can varies in number
through the different parasite’s stages [22,23]. The results
from the dilution series, containing ring stage parasites ex-
clusively, showed the same threshold detection level for all
three genus-specific PCR assays, though the mitochon-
drial PCR had highest sensitivity on this detection level. In
ring stage parasites the copy number of the mitochondrial
genome is approximately three to four times higher than
the copy number of the 18S locus. Compared to 18S PCR,
the mitochondrial PCR detected one more sample
among the patient material, and notably none of the four
18S PCR assays (two genus-/ and two species-specific)
detected this sample. The patient had recrudescence fol-
lowing primary P. falciparum infection two weeks earlier.
Maturation of P. falciparum gametocytes takes eight to
10 days [27,28]. Although microscopy detected one single
ring stage parasite, the difference in sensitivity in this sam-
ple is possibly due to submicroscopic gametocytaemia; the
copy number of the mitochondrial genome in a gameto-
cyte is approximately 10 to 32 times higher than the copy
number of the 18S locus.
Due to short product size, 220 bp, the amplification
time with the new mitochondrial PCR programme takes
one-and-a-half hours less than the modified 18S PCR
programme, and three hours less than nested 18S PCR
[10]. Another advantage of the short product size, was
that the mitochondrial PCR products could be easily
full-length sequenced. As an alternative to species-
specific PCR, the SNPs found in the sequences allowed
Figure 3 Sequencing of Plasmodium genus-specific mitochondrial PCR products reveals polymorphisms consequently identifying
malaria species. Sequencing of the genus-specific mitochondrial PCR products, employing primers PgMt19 F3&B3 [21], gave high-quality
sequences of full length. Run through BLAST the results showed that the four species were distinguished by two to six single nucleotide
polymorphisms and one insert/deletion consequently allowing sequencing to be used as an alternative species-specific determination method in
our cohort.

















18 Pf Pf Pf Pf
1 Pf Pf + Pm Pf + Pm Pf
1 Pf Negative Negative Pf
3 Pv Pv Pv Pv
1 Pv Pv Pv Negative
1 Pv Pv Pv Pf + Pv
1 Pv Pv1 Pv1 Pk2
1 Po Po Po Pf + Po
1 Pm Pm Pm Negative
Abbreviations: Pf, Plasmodium falciparum; Pv, Plasmodium vivax; Po,
Plasmodium ovale; Pm, Plasmodium malariae; Pk, Plasmodium knowlesi.
1 Plasmodium knowlesi primers were not included in the assay.
2 Evaluated as inconclusive species by microscopy, but with emphasis on
possible Plasmodium knowlesi infection.
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for specific species determination (Figure 3). However
the validity of the SNPs warrants further investigation to
evaluate if the SNPs are universal in different strains of
the species. All of the 28 sequences correctly identified
species compared to the species confirmed by either the
species-specific 18S PCR assays or microscopy. However,
sequencing only identified P. falciparum species in a
double infection with P. malariae, which was detected
by both the species-specific 18S PCR assays. This can be
explained by P. falciparum predominance due to its
ability to induce high parasitaemia. Despite missing the
less numerous species in mixed infections, sequencing of
the mitochondrial PCR products can be useful in species
diagnosis. Compared to a species-specific multiplex PCR,
the sequencing method avoids unwanted cross-bindings
due to similar primers’ hybridization sites, difficulties in
interpreting results due to similar product sizes, and lower
sensitivity due to competing primers. Due to high quality
sequences this method only requires one reaction for
every positive sample to perform species determination,
compared to four/five in non-multiplex species-specific
PCR assays. Sequencing of positive mitochondrial PCR
products also allows for identification of species where
species-specific 18S PCR assays may fail to detect low
parasitaemia, as shown in the sample with recrudescence
in this patient cohort. The simple and rapid mitochondrial
PCR assay, with the advantages of high sensitivity and that
species-specific sequencing is possible in positive samples,
might therefore have a value in screening purposes, espe-
cially in large scale epidemiologic and surveillance studies
as well as in diagnostics.
Conclusions
In this study two simple and rapid single-round amplifi-
cation assays for detection of malaria were described.
The novel mitochondrial PCR was the only method with
100% sensitivity in this patient cohort, and both its sen-
sitivity and specificity was statistically non-inferior to
that of the reference 18S nested PCR [10]. The method
may be of particular value in samples of low parasitaemia/
gametocytaemia and in large-scale studies. Sequencing of
the genus-specific mitochondrial PCR products or devel-
oping the assay to real-time PCR could be an alternative
to species-specific PCR in species determination.
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P 1 Negative 01 Pm Pm Primary Ghana Pm overlooked by microscopy
P 2 Negative2 01 Pv Pv Primary New
Guinea
Pv overlooked by microscopy




Inconclusive/ incorrect diagnosis by
microscopy
P 3 Pf + Po <1% Po Po Recurrent
(Relapse)
Uganda Over-diagnosed mixed infection by
microscopy
P 4 Pf <1% Pf + Pm Pf Primary Liberia Under-diagnosed mixed infection by
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P 5 Pf + Pv 1% Pv Pv Primary3 SEA or CA Over-diagnosed mixed infection by
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Approximately one million malaria cases were reported in India in 2015, based on micros-
copy. This study aims to assess the malaria prevalence among hospitalised fever patients
in India identified by PCR, and to evaluate the performance of routine diagnostic methods.
Methods
During June 2011-December 2012, patients admitted with acute undifferentiated fever to
seven secondary level community hospitals in Assam (Tezpur), Bihar (Raxaul), Chhattis-
garh (Mungeli), Maharashtra (Ratnagiri), Andhra Pradesh (Anantapur) and Tamil Nadu
(Oddanchatram and Ambur) were included. The malaria prevalence was assessed by poly-
merase chain reaction (PCR), routine microscopy, and a rapid diagnostic test (RDT) with
PCR as a reference method.
Results
The malaria prevalence by PCR was 19% (268/1412) ranging from 6% (Oddanchatram,
South India) to 35% (Ratnagiri, West India). Among malaria positive patients P. falciparum
single infection was detected in 46%, while 38% had P. vivax, 11%mixed infections with P.
falciparum and P. vivax, and 5% P.malariae. Compared to PCR, microscopy had sensitivity
of 29% and specificity of 98%, while the RDT had sensitivity of 24% and specificity of 99%.
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Conclusions
High malaria prevalence was identified by PCR in this cohort. Routine diagnostic methods
had low sensitivity compared to PCR. The results suggest that malaria is underdiagnosed in
rural India. However, low parasitaemia controlled by immunity may constitute a proportion
of PCR positive cases, which calls for awareness of the fact that other pathogens could be
responsible for the febrile disease in submicroscopic malaria.
Introduction
Malaria is one of the leading infectious causes of morbidity and death. TheWorld Health Orga-
nization (WHO) estimated 214 million malaria cases and 438,000 malaria deaths globally in
2015 [1]. In India 1,102,205 malaria cases and 561 deaths were reported in 2015 based on
microscopy and rapid diagnostic tests (RDT) [1]. Less than two malaria cases per thousand
individuals per year (Annual Parasite Index (API)) is reported in most parts of India, lowest in
South-, North- andWest, and highest in Central-, East- and North-East [2]. However, data
from malaria surveillance are uncertain since a majority of the population live in poverty in
rural areas and has limited access to diagnostic services, and recent studies have shown that
malaria prevalence and case fatality is underreported by surveillance systems [2, 3].
Routine malaria diagnostic methods have several limitations compared to polymerase chain
reaction (PCR). Accurate microscopy requires skilled personnel and high quality technical
equipment [4], and commercially available RDTs differ widely in sensitivity and specificity [5].
Both methods fail to detect low-level parasitaemia, and are inferior in optimal species identifi-
cation [4, 5]. In principle, PCR can detect parasitaemia as low as one gene copy, and allows
differentiation of all five Plasmodium species [6, 7]. In point of care diagnosis, PCR cannot
replace the traditional diagnostic methods, as the technique is relatively costly, resource-
demanding and time-consuming. However, using PCR as a reference method provides more
accurate information about prevalence and species distribution [8, 9]. Furthermore, within the
variety of PCR protocols, the choice of gene target influences the sensitivity of PCR. Targeting
the mitochondrial genome yield higher sensitivity than the common 18S gene due to a higher
number of gene copies per parasite [10, 11].
The primary objective of this study was to assess the proportion of malaria infections
among patients with acute undifferentiated fever, presenting to secondary level community
hospitals at multiple sites across India, using a highly sensitive and specific PCR targeting mito-
chondrial DNA as a reference method [11]. The secondary objective was to evaluate the sensi-
tivity, specificity and species-specificity of routine microscopy and RDT compared to PCR.
Materials and Methods
Study design and population
The present work was part of a multi-centre, observational, cross sectional study, investigating
the proportion of acute undifferentiated fever attributable to different infections. From June
2011 to December 2012, 1564 patients admitted to seven hospitals in rural or semi-urban areas
in six different states of India, were enrolled prospectively and consecutively. Inclusion criteria
was inpatients aged5 years with temperature38°C for 2–14 days prior to admission, with
no localized causes of fever. Patients received health care according to routines at the partici-
pating hospitals, and no additional interventions were performed as part of the study.
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Study sites
The study sites were located in Tezpur (Assam, North East India), Raxaul (Bihar, East India),
Mungeli (Chhattisgarh, Central India), Ratnagiri (Maharashtra, West India), Anantapur
(Andhra Pradesh, South India), Oddanchatram and Ambur (Tamil Nadu, South India). Fig 1
shows the locations of the study sites. These are secondary level community hospitals with 100
to 500 beds. The rainy seasons vary between the sites, as outlined in the result section present-
ing seasonal variations. The Benjamin M Pulimood Laboratories for Infection and Inflamma-
tion, Department of Medicine Unit 1 and Infectious Diseases, Christian Medical College,
Vellore, India served as study coordinating centre and reference laboratory.
Study procedures
Blood (0.5–1 ml and 3–5 ml from paediatric and adult patients, respectively) was drawn into
EDTA tubes and stored at -20°C at the study sites before they were bulk shipped on dry ice to
the coordinating centre, where molecular and antigen testing for malaria was performed. Test
analyses were performed blinded from other test results. Peripheral blood smears were pre-
pared and examined for malaria parasites at the study sites as part of the routine microscopy
work-up according to the hospitals procedures. Technicians were trained and involved in rou-
tine smear examination at the respective sites, and were retrained at the reference laboratory
during the start of the study. Quality control slides were sent to the sites and reported back to
the reference laboratory in a satisfactory manner.
DNA for PCR analysis was extracted from 200 μl whole blood using QIAamp DNA Blood
Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer’s instructions, and stored
at -20°C prior to application. All samples were screened for presence of PlasmodiumDNA by a
genus-specific pan-malaria PCR assay targeting the mitochondrial genome. The assay was
done as previously described [11], but with a primer concentration of 1μM. In case of discor-
dant results between PCR, RDT or routine microscopy, the samples were retested by the
Fig 1. Location of seven community hospitals in six states of India participating in the study.
doi:10.1371/journal.pone.0158816.g001
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genus-specific PCR from the extraction step as a quality control. A malaria infection was con-
firmed if two or all of the three repeat PCRs were positive.
All genus-specific PCR positive samples were further analysed by a species-specific PCR tar-
geting the 18S of P. falciparum, P. vivax and P.malaria. A modified version of the original
protocol by Padley et al. [12] was used as described previously [11]. Samples negative by the
species-specific PCR, were repeated by the genus-specific PCR and the PCR products were
thereby sequenced for species identification as described previously [11]. The sequencing could
potentially identify all five species including P. ovale and P. knowlesi.
Amplifications were done on AB Applied Biosystem veriti 96 well Thermal cycler (Applied
Biosystems, Carlsbad, CA, USA), and products detected by electrophoresis on a 2% SeaKem
agarose gel (Lonza, Rocland, ME, USA) stained with ethidium bromide.
The EDTA-blood samples, stored at -20°C, were also tested with the RDT ParaHIT-Total
Ver. 1.0 Device 55IC204-10 (Span Diagnostics Ltd, Surat, India) at the reference laboratory fol-
lowing manufacturer’s instructions. It detects P. falciparum specific Histidine-Rich-Protein II
and aldolase antigen of pan-malaria species (P. falciparum, P.malariae, P. vivax, and P. ovale).
The test card has two regions, ‘Pf’ and ‘Pan’. A red band in the ‘Pf’ region alone indicates that
the sample is reactive for P. falciparum (usually in case of low parasitaemia). Red bands in both
‘Pf’ and ‘Pan’ region indicate either single infection by P. falciparum or a mixed infection of P.
falciparum with P. vivax, P. ovale or P.malariae. Appearance of a red band in the ‘Pan’ region
alone indicates that the sample is reactive for infection by a malaria species other than P.
falciparum. The RDT kits were quality checked using known positive and negative controls.
Statistical analysis
Confidence intervals for tests’ sensitivities, specificities, positive and negative predictive values
were calculated using the cii command in Stata 14 (StataCorp, College Station, TX, USA), and
presented as exact 95% confidence intervals.
Ethical approval
The study was approved by the Institutional Research Board at Christian Medical College, Vel-
lore, Tamil Nadu (No. 7242 dated 11th of August 2010) and by the Regional Ethics Committee
of Norway (2010/2271-5). Written, informed consent was obtained from the patients.
Results
Among patients enrolled in the acute fever study (N = 1564), samples from 1412 patients were
available for malaria PCR testing, and these patients were included in the analyses. Fig 2 shows
a flowchart of the investigations performed based on results and samples available. Among the
1412 patients, 815 (58%) were men, and 584 (41%) women. Mean (median) age was 34 (32)
years, and 177 (13%) patients were 14 years old.
Prevalence of malaria by PCR, all species
Genus-specific PCR identified a malaria prevalence of 19% (268/1412) as shown in Table 1.
The prevalence varied from 6% (19/318) in Oddanchatram in South India to 35% (85/245) in
Ratnagiri in West India.
Seasonal variations in malaria prevalence is shown in Fig 3. Increased number of PCR posi-
tive cases were seen during or short after the rainy seasons at most of the sites.
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Species distribution by PCR
Species determination by species-specific PCR or sequencing was performed on samples from
251 patients (Fig 2). Overall, P. falciparum single infection was detected in 46%, while 38% had
P. vivax single infections, and 11% had mixed infections with P. falciparum and P. vivax. Spe-
cies distribution at the sites is presented in Table 2. P. falciparum dominated in Mungeli (Cen-
tral India), Raxaul (East India) and Anantapur (South India). In Ambur (South India), P. vivax
accounted for the majority. In Ratnagiri (West India), Oddanchatram (South India) and Tez-
pur (North-East India) the difference in P. vivax and P. falciparum distribution was less promi-
nent. Mixed infections with P. falciparum and P. vivax were detected in a high number of
Table 1. Malaria prevalence by PCR among patients admitted with acute undifferentiated fever to
seven community hospitals across India, (N = 1412).
Sites N* Malaria PCR positives
N (%)
Total 1412 268 19
Ratnagiri (West India) 245 85 35
Raxaul (East India) 106 30 28
Mungeli (Central India) 52 13 25
Anantapur (South India) 124 28 23
Tezpur (North-East India) 293 49 17
Ambur (South India) 274 44 16
Oddanchatram (South India) 318 19 6
*Total number of samples examined with malaria genus-specific PCR.
doi:10.1371/journal.pone.0158816.t001
Fig 2. Flowchart showing investigations performed based on results and samples available.
doi:10.1371/journal.pone.0158816.g002
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patients in Anantapur, Ambur, and Tezpur. P.malariae was found at all sites except Mungeli
and Raxaul. P. ovale was not detected in any of the patients.
Performance of routine microscopy and RDT compared to PCR
Among the 1412 samples analysed by PCR, 1168 samples were analysed with routine micros-
copy and 1407 with RDT (Fig 2).
The total malaria prevalence detected by microscopy and confirmed positive by PCR was
6% (66/1168); at Ratnagiri 12% (29/267), Raxaul 2% (2/100), Mungeli 28% (2/5), Anantapur
8% (9/113), Tezpur 5% (14/276), Ambur 6% (7/117) and Oddanchatram 1% (3/318). Among
these malaria patients, 92% (61/66, missing values 1/66) were adults ( 14 years old), and
among PCR positive patients with negative microscopy, 85% (137/162, missing values 10/162)
Fig 3. Seasonal variation amongmalaria PCR positive cases. The sites have the following rainy seasons:
Oddanchatram; June to December, with peak monsoon from October to December. Ambur; June to
December, with a peak monsoon from October to December. Ratnagiri; June to November. Mungeli; June to
September, or early October. Anantapur; Dry climate, but rainy season fromMay to October, with its peak in
September. Tezpur; April to September, with peak monsoon in July and August. Raxaul; July to September,
with peak monsoon in August.
doi:10.1371/journal.pone.0158816.g003
Table 2. Malaria species distribution by PCR, (N = 251).
Sites N* P.f P.v P.f+P.v P.m P.f+P.m P.v+P.m
N (%) N (%) N (%) N (%) N (%) N (%)
Total 251 116 (46) 96 (38) 27 (11) 9 (4) 2 (1) 1 (0.4)
Mungeli 13 11 (85) 1 (8) 1 (8) 0 0 0
Raxaul 19 15 (79) 4 (21) 0 0 0 0
Anantapur 27 14 (52) 7 (26) 5 (19) 1 (4) 0 0
Tezpur 44 20 (46) 15 (34) 6 (14) 3 (7) 0 0
Ratnagiri 85 37 (44) 39 (46) 7 (8) 0 1 (1) 1 (1)
Oddanchatram 19 8 (42) 6 (32) 1 (5) 3 (16) 1 (5) 0
Ambur 44 11 (25) 24 (55) 7 (16) 2 (5) 0 0
Abbreviations: P.f, Plasmodium falciparum; P.v, Plasmodium vivax; P.m, Plasmodium malariae.
*Total number of malaria genus-specific PCR positive samples available for species determination by either species-specific PCR or sequencing.
doi:10.1371/journal.pone.0158816.t002
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were adults. Compared to PCR the sensitivity of routine microscopy was 29% (Table 3).
Among false positive blood slides, 18/22 was from one site, indicating high specificity of rou-
tine microscopy in six of the seven hospitals.
Compared to PCR the sensitivity of the RDT was as low as 24%, while only 1% (10/1407)
was false positive (Table 3). The total prevalence of malaria detected by RDT confirmed posi-
tive by PCR was 5% (65/1407); at Ratnagiri 7% (17/242), Raxaul 3% (3/106), Mungeli 12%
(6/52), Anantapur 7% (9/124), Tezpur 5% (16/292), Ambur 4% (11/274) and Oddanchatram
1% (3/317).
The species concordance between PCR and routine microscopy is presented in Table 4.
Microscopy was more likely to correctly identify P. vivax than P. falciparum. None of the P.
malariae infections were detected by microscopy.
Table 5 presents species identification by RDT compared to PCR. Only one mixed infection
was detected and RDT misidentified seven P. falciparummalaria infections as non-falciparum.
None of the P.malariae single infections were detected by RDT.
S1 Table shows a comparison of the concordance among the three methods (N = 1163).
Negative RDT among patients positive both by routine microscopy and PCR, was found in
38% (25/66), while negative microscopy among those positive both by RDT and PCR was
found in 31% (18/59). Only 5% (2/43) were negative by PCR among those positive both by
microscopy and RDT.
Table 3. Performance of routine microscopy and RDT compared to PCR.
Routine microscopy RDT
(N = 1168) (N = 1407)
Percentage, 95% CI, n/total Percentage, 95% CI, n/total
Sensitivity 29% (23%-35%), 66/228 24% (19%-30%), 65/268
Specificity 98% (96%-99%), 918/940 99% (98%-100%), 1129/1139
Positive predictive value 75% (65%-84%), 66/88 87% (77%-93%), 65/75
Negative predictive value 85% (83%-87%), 918/1080 85% (83%-87%), 1129/1332
doi:10.1371/journal.pone.0158816.t003
Table 4. Malaria species concordance between PCR and routinemicroscopy results, (N = 1168).
Routine microscopy
P.f P.v P.f+P.v P.o Positive1 Neg
(N = 26) (N = 50) (N = 5) (N = 1) (N = 6) (N = 1080)
PCR P.f (N = 100) 14 8 1 1 1 75
P.v (N = 81) 3 21 3 0 2 52
P.f+P.v (N = 20) 1 4 1 0 1 13
P.m (N = 8) 0 0 0 0 0 8
P.f+P.m (N = 2) 0 0 0 0 0 2
P.v+P.m (N = 1) 0 1 0 0 0 0
Positive1 (N = 16) 2 1 0 0 1 12
Negative (N = 940) 6 15 0 0 1 918
Abbreviations: P.f, Plasmodium falciparum; P.v, Plasmodium vivax; P.o, Plasmodium ovale; P.m, Plasmodiummalariae.
Data shown for all patients examined by both PCR and microscopy.
1Species identification not available.
doi:10.1371/journal.pone.0158816.t004
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Discussion
In this study, among hospitalized patients with acute undifferentiated fever in six states of
India, we report a malaria prevalence as high as 19% using a sensitive PCR [11], compared to a
prevalence of 6% identified by routine microscopy confirmed by positive PCR.
There are to our knowledge no previous hospital based malaria prevalence studies using
PCR from the areas in the present study, and only a limited number of microscopy based
reports. Two studies fromMaharashtra (West India) among hospitalised fever patients
reported a malaria prevalence of 10% (44/448) and 12% (144/1197) [13, 14], while the present
study found a prevalence of 35% in Ratnagiri, Maharashtra. From Assam (North-East India)
one multicentre study reported a malaria prevalence of 30% (97/324) among hospitalised fever
patients [15], which is higher than the prevalence of 17% found in Tezpur, Assam. No hospital
based studies are available from Chhattisgarh (Central India) where we found a prevalence of
25% in Mungeli, however, high malaria prevalence is reported in community based surveys
from the neighbouring states Madhya Pradesh (Central India) and Orissa (East India) [16–18].
High prevalence, 16% and 23%, was found in the southern sites Ambur (Tamil Nadu) and
Anantapur (Andhra Pradesh) in line with a study from a tertiary care hospital in Tamil Nadu
reporting a malaria prevalence of 17% among fever patients [19].
During the last 30 years there has been an increasing incidence of P. falciparum compared
to P. vivax in India, which has been attributed to chloroquine resistance in P. falciparum [20,
21]. Our findings supported this trend; PCR identified 46% single P. falciparum versus 38%
single P. vivax infections. Predominance of P. falciparum is reported in West-, Central-, East-
and North East India, and predominance of P. vivax in North- and South India [1], partly in
line with the present study, where Ambur (Tamil Nadu) had the highest proportion of P. vivax
(55%), and predominance of P. falciparum was found in the sites in Andhra Pradesh, Bihar,
Chhattisgarh and Assam. However, also in Oddanchatram in Tamil Nadu the proportion of P.
falciparum was higher than of P. vivax. Predominance of P. falciparum is expected among hos-
pitalized malaria patients who are more prone to have severe disease, and species distribution
in this study is not representative for malaria in the community population. However, the find-
ing of P. falciparum predominance in the majority of the sites underlines the importance of
considering P. falciparum aetiology in febrile patients in all parts of India. Furthermore, a high
Table 5. Malaria species concordance between PCR and RDT results, (N = 1407).
RDT
P.f Pan P.f+Pan Positive2 Neg
(N = 9) (N = 37) (N = 27) (N = 2) (N = 1332)
PCR P.f (N = 116) 6 3 19 0 88
P.v (N = 96) 0 23 2 0 71
P.f+P.v (N = 27) 0 4 1 0 22
P.m (N = 9) 0 0 0 0 9
P.f+P.m (N = 2) 0 0 0 0 2
P.v+P.m (N = 1) 0 1 0 0 0
Positive1 (N = 17) 1 3 2 0 11
Negative (N = 1144) 2 3 3 2 1129
Abbreviations: P.f, Plasmodium falciparum; P.v, Plasmodium vivax; P.m, Plasmodium malariae.
Data shown for all patients examined with both PCR and RDT.
1Species identification not available.
2Species identification not recorded.
doi:10.1371/journal.pone.0158816.t005
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proportion of double infections (12%) were detected as supported by previous PCR studies in
India [8, 9, 22].
The sensitivity detecting malaria infections by routine microscopy in the present study was
only 29%, supported by several other field studies reporting low sensitivity of routine micros-
copy compared to PCR [23–25]. One study using PCR among fever patients in Orissa in India,
reported a malaria prevalence of 81% by PCR compared to 43% by microscopy [8]. In a review
of studies comparing PCR and microscopy, PCR detected on average twice as many malaria
infections [26]. The low sensitivity by microscopy can be due to suboptimal staining, poor
quality and inadequately maintained microscopes, and microscopists who are insufficiently
trained or fatigued by high workload. However, even under optimal conditions microscopy-
based diagnosis does not achieve the low detection limits that PCR-based methods yield. The
PCR applied in the present study has a sensitivity of at least 0.5 parasites/μl [11], and an experi-
enced person in a reference laboratory would not be expected to detect parasitaemia lower than
50 parasites/μl by microscopy [4]. Furthermore, the low species-specificity of microscopy com-
pared to PCR in the present study is supported by similar findings in previous PCR studies
from India [8, 9, 22].
In the present study RDT had a sensitivity as low as 24% compared to PCR, and>50% of
the PCR positives which were negative by RDT were P. falciparum. The RDT ParaHIT-Total
Device (Span Diagnostics) was chosen as it was widely used in routine diagnostics, easily avail-
able, reasonably priced, and could be stored at room temperature (25°C). In 2014 a study from
India reported 70% sensitivity of this RDT compared to microscopy in detecting P. falciparum
[27]. The sensitivity of the P. falciparum specific RDT ParaHIT f (Span Diagnostics) compared
to microscopy ranged from 11% and 30%, respectively, in two Tanzanian studies [28, 29], to
85% in an Indian study [30]. According to the WHO’s evaluation of RDTs, the ParaHIT-Total
Device detect 200 P. falciparum parasites/μl with a detection score of 85% [5], supporting that
malaria with low parasitaemia probably constitute a proportion of the cases detected by PCR in
this cohort.
The low sensitivity of microscopy and RDT compared to PCR may have two potential
causes with impact on case management: True low sensitivity of routine diagnostics or asymp-
tomatic parasitaemia in patients with other infections. Challenges regarding routine diagnos-
tics in resource poor settings has been described above. A challenge using PCR in clinical
diagnosis is that the method potentially also detects low parasitaemia in semi-immune individ-
uals and not the true cause of fever. The pathogen actually causing the febrile disease may
thereby be overlooked. In the present study, submicroscopic malaria was detected by PCR in
71% (162/228), and the level of asymptomatic malaria, and another infection responsible for
the febrile disease, among these is unknown. Submicroscopic and asymptomatic malaria is not
restricted to high endemic regions; increased prevalence has been reported from areas of low
transmission intensity [31–34], and varying prevalence of asymptomatic malaria from different
parts of India has been reported. Based on microscopy, two studies in tribal populations in
Eastern India reported a prevalence of asymptomatic malaria of 8% and 25% respectively [35,
36], while two studies among pregnant women attending antenatal clinics in Jharkhand (East
India) and Chhattisgarh (Central India) reported prevalence of asymptomatic parasitaemia as
low as 1% (21/1985) and 0.5% (12/2457) respectively [37, 38]. Submicroscopic malaria is
reported to be more common in adults due to the effect of acquired immunity [31, 39, 40]. The
proportion of malaria identified only by PCR was not higher among adults than children in the
present study.
In addition to the probability of parasitaemia controlled by immunity, a proportion of the
patients in this cohort potentially suffering from a nonmalarial cause of fever, could have posi-
tive malaria PCR explained by other mechanisms. PCR may remain positive for several weeks
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after effective malaria treatment, which is probably explained by residual asexual parasites and/
or gametocytaemia [33]. The mitochondrial PCR is particularly sensitive in detecting gameto-
cytes because this parasite stage harbour up to eight mitochondria organelles, compared to the
ring stage which harbours only one organelle [41]. In order to further elucidate the clinical
impact of PCR positive malaria, quantitative real-time PCR, and gametocyte specific reverse
transcriptase PCR, are methods that can be performed [42, 43]. In clinical practice in malaria
endemic areas, other causes of febrile disease, such as bacterial sepsis, should be ruled out also
when malaria parasites are detected, especially when there is low parasitaemia.
Although there is a risk for over-diagnosing malaria as the cause of febrile disease by PCR,
the fact that the method detects low density parasitaemia, undetected by microscopy and RDT,
underlines the need for accessible molecular tools for better diagnosis and estimations of the
true malaria burden in India. Further, in control and elimination strategies, PCR is essential for
detection of submicroscopic and asymptomatic malaria which contribute to the infectious res-
ervoir of the disease [31, 33, 39, 40].
A potential limitation regarding the distribution of malaria across the sites is that a propor-
tion of the patients may have contracted malaria in another area than they were hospitalised.
Further, occurrence of selection bias in the inclusion of patients and samples in the favour of
clinically suspected malaria cannot be ruled out. Ineffective adherence to routines in a PCR lab-
oratory can result in false positivity due to contamination. Contamination can occur in all
steps of the procedure, but it is especially important to limit accumulation of amplification
products in the laboratory environment [44]. Substantial effort was given to preparations and
training to set the PCR contamination risk to a minimum, with focus on executing the different
steps in separate rooms, strict routines for maintaining a sterile environment, correct handling
of samples etc. All genus-specific PCR results with discordancy with either RDT or microscopy
were re-tested from the DNA extraction step, as a quality control.
Conclusions
This multi-centre study from secondary level community hospitals in six states in India,
reports a high prevalence of malaria among patients admitted with acute undifferentiated
fever, applying PCR as the reference method. Routine microscopy and RDT had low sensitivity
and species-specificity compared to PCR. As PCR is often not available or feasible in routine
diagnostics, RDT and microscopy remains the mainstay in work-up of fever patients. The
results of this study calls for awareness of the importance of quality assurance of malaria rou-
tine diagnostics. In work up of hospitalised febrile patients it should also be taken into consid-
eration that patients with low parasitaemia might serve as a reservoir for transmission rather
than suffering from clinical malaria, and other potential causes of fever should be ruled out.
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Abstract
In epidemiological surveys and surveillance the application of molecular tools is essential in
detecting submicroscopic malaria. A genus-specific conventional cytochrome b (cytb) PCR
has shown high sensitivity in field studies, detecting 70% submicroscopic malaria. The main
objective of this study was to assess the conversion from conventional to real-time PCR
testing both SYBR and probe protocols, and including quantitative (q) PCR. The protocols
were assessed applying well-defined clinical patient material consisting of 33 positive and
80 negative samples. Sequencing of positive PCR products was performed. In addition, a
sensitivity comparison of real-time PCR methods was done by including five relevant assays
investigating the effect of amplification target and platform. Sensitivity was further examined
using field material consisting of 111 P.falciparum positive samples from Tanzanian children
(< 5 years), as well as using related patient data to assess the application of q-PCR with
focus on low-level parasitaemia. Both the cytb SYBR and probe PCR protocols showed as
high sensitivity and specificity as their conventional counterpart, except missing one P.
malariae sample. The SYBR protocol was more sensitive and specific than using probe.
Overall, choice of amplification target applied is relevant for achieving ultra-sensitivity, and
using intercalating fluorescence dye rather than labelled hydrolysis probes is favourable.
Application of q-PCR analysis in field projects is important for the awareness and under-
standing of low-level parasitaemia. For use in clinical diagnosis and epidemiological studies
the highly sensitive and user-friendly cytb SYBR q-PCR method is a relevant tool. The
genus-specific method has the advantage that species identification by sequencing can be
performed as an alternative to species-specific PCR.
Introduction
Malaria is a major threat to global health with half the world’s population being at risk of get-
ting infected. In 2016 there were 216 million malaria cases causing almost half a million deaths,
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particularly among children in Sub-Saharan Africa and India [1]. The World Health Organisa-
tion has identified 21 countries that may be able to eliminate malaria by 2020 [1]. Healthy,
asymptomatic humans carrying malaria parasites in the blood represent a reservoir for trans-
mission [2], and are a key challenge to the elimination of malaria [3, 4]. Polymerase chain reac-
tion (PCR) methods have gained a strong foothold in research and epidemiology during the
last two decades. PCR has shown to be superior in sensitivity and specificity compared to
microscopy and rapid diagnostic tests (RDT) [5–8]. However, there is still need to further
improve the performance of malaria PCR techniques and to develop quantitative methods for
field studies, to address the issue of asymptomatic carriage of malaria, and to increase our
understanding of malaria epidemiology which may help improve control and elimination
strategies [4, 6].
Visualizing conventional PCR products by gel electrophoresis is time-consuming and
resource-demanding, and increases the risk of contamination. With real-time PCR the detec-
tion step is incorporated into the amplification; for each cycle, target DNA is directly detected,
usually by either intercalating SYBR green, or fluorescence labelled hydrolysis probes [9, 10].
The direct detection allows for quantitative results (q-PCR), presented either by standard cycle
threshold (Ct) values, which is inversely proportional to the amount of target DNA in the sam-
ple, or even more exact quantitation by applying a known dilution series of target DNA (for
example customized plasmid) which serves as a standard curve to determine the number of
target copies per volume in the sample. Thus, q-PCR could be a highly valuable tool to study
low-level malaria parasitaemia [10, 11].
During the last decade, there has been a focus on the use of amplification targets with a
high copy number in the malaria genome to increase the sensitivity of the PCR. Examples of
these multi-targets are chromosomal small subunit ribosomal RNA 18S locus, cytochrome b
gene (cytb) on the mitochondrial genome, the chromosomal subtelomeric targets telomere-
associated repetitive element 2 (TARE-2) and var gene acidic terminal sequence (varATS).
The first malaria PCR methods were based on the 18S target, which typically exists in five to
eight copies in P. falciparum [12]. Subsequently, mitochondrial targets, such as cytb, emerged
since the genome is conserved and exists in about 20–160 copies depending on the develop-
ment stage [13, 14]. In 2015 two new multi-targets were reported; TARE-2, which exists in
about 250–280 copies due to 10 to 12 repeat units presented at 24 of 28 subtelomeric
sequences, and varATS which exists in about 59 copies and is encoding the P. falciparum
erythrocyte membrane protein 1 [15].
A genus-specific cytb conventional PCR [16] has proved to be highly sensitive and specific
in field studies [5, 17]. The main objective of the present study was to develop a robust screen-
ing tool by converting the conventional PCR to a real-time PCR, evaluate two different fluores-
cent dyes SYBR green and TaqMan probe, and to assess the assays using well-defined patient
materials from clinical and field collections [5, 16, 18]. Secondary objectives were to compare
relevant real-time methods in order to investigate the effect the choice of platform (SYBR ver-
sus probe) and amplification target has on sensitivity, and to implement q-PCR analysis on
patient data from field material with focus on low-level parasitaemia.
Materials and methods
Samples
All sample material applied in this study was stored DNA (-20/80˚C), which had been
extracted either from whole blood using QIAamp DNA Blood Mini Kit (Qiagen, Hilden, Ger-
many) according to the manufacturer’s instructions, or from filter paper applying Chelex-100
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Molecular Biology Grade Resin (Bio-Rad Laboratories, Hercules, CA, USA) as previously
described [19].
The clinical patient material, used to assess the sensitivity and specificity of the designed
cytb SYBR/TaqMan real-time assays, was a defined collection of 33 confirmed positive (18 P.
falciparum, eight P. vivax, three P. ovale, two P. malariae, and two P. falciparum + P. malariae),
and 80 confirmed negative samples, from 113 fever patients with potential malaria collected
between 2006 and 2013 at Haukeland University Hospital, Bergen, Norway [16]. The consen-
sus on which samples were positive or negative was based on results from previously per-
formed analyses by routine microscopy, the PCR reference method described by Singh et al.
[20], a genus-specific cytb PCR, a species-specific 18S PCR (all conventional), and sequencing
[16].
The field material, used to investigate sensitivity and to perform q-PCR, was a defined col-
lection of 111 positive P.falciparum DNA samples (74 patients), where 74 were extracted from
200 μl EDTA whole blood, and 37 from filter papers. The DNA was obtained from 304 chil-
dren who were hospitalized due to febrile illness between January and June 2009 at the general
pediatric wards at Muhimbili National Hospital, Dar es Salaam, Tanzania [5, 18]. The samples
were confirmed positive by the same genus-specific cytb, and species-specific 18S conventional
PCR assays (or sequencing) as the Norwegian cohort [16]. Clinical and demographic data,
such as age, gender, travel outside Dar es Salaam the last four weeks, referral from other hospi-
tals, any use of antibiotics or antimalarial drugs the last four weeks, length of sickness, other
clinical diagnoses, and outcome, were included in the analysis of potential correlation with
level of parasitaemia by q-PCR. Details regarding the study population and clinical findings in
the Tanzanian field study have been reported previously [5].
Reference material
To compare the sensitivity of seven different real-time PCR methods a reference strain of P.
falciparum (US 03 F FC27/A3), containing exclusively ring stage parasites in a concentration
of 2000 parasite/μl (p/μl), was diluted in RNase-free water (Qiagen) into the following dilu-
tions: 5 p/μl, 1 p/μl, 0.5 p/μl, 0.1 p/μl, and 0.05 p/μl, run in 12 parallels. In addition, a 10-fold
dilution series run in triplicates, 2000–0.2 p/μl, was included to assess the amplification effi-
ciency (E) of the real-time assays.
Customized plasmid for q-PCR
To serve as a standard curve for q-PCR, a custom designed EcoRI linearized q-PCR template,
with a pUCminusMCS vector backbone and this study’s cytb amplification target (220 bp) as
insert (OriGene Technologies, Rockville, MD, USA), was applied in a 10-fold dilution series,
range 2.7 x 108–2.7 copies of target DNA/reaction (rxn), run in duplicates.
PCR methods
A conventional single-step genus-specific cytb PCR [16] was converted to one SYBR and one
TaqMan real-time PCR protocol using the same primers.
To investigate sensitivity differences/trends, and effects the number of copies of the amplifi-
cation targets may have, five relevant and comparable real-time PCR methods were included.
Table 1 shows the characteristics of the real-time PCR assays.
Otherwise, the protocols for the five included real-time PCR methods were carefully fol-
lowed as previously described [15, 21–23].
For the cytb SYBR/TaqMan real-time PCR protocols designed and optimized in this study
the following primers were applied: PgMt19 F3 forward (5’-tcg ctt cta acg gtg aac) and PgMt19
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B3 reverse (5’-aat tga tag tat cag cta tcc ata g), previously published for a loop-mediated iso-
thermal amplification method [24]. The primer concentration was 600 nM of each primer,
and 200 nM of the TaqMan probe PgMt(28)-Probe 6-FAM-ctt cta aca ttc cac ttg ctt ata act g-
BHQ-1 (Eurogentec, Seraing, Belgium). In addition, the reaction mix contained 1 mM MgCl2
(New England BioLabs, Ipswich, MA, USA). Both protocols used the following cycling param-
eters; step 1, 50˚C for 2 min; step 2, 95˚C for 10 min; step 3, denaturation at 95˚C for 15 sec;
step 4, annealing at 59˚C for 50 sec; and step 5, amplification at 72˚C for 10 sec, steps 3–5
repeated 45 times.
To investigate the quality of the stored DNA, samples of extremely low parasitaemia were
reanalysed with the cytb conventional PCR (primers PgMt19 F3&B3), run in triplicates, as pre-
viously described by Haanshuus et al. [16], but with a primer concentration of 1 μM (incorrect
concentration given in the publication [16]).
To ensure that real-time PCR products showed the same high quality sequences for species
identification as for the cytb conventional PCR [16], all positive products amplified by the cytb
SYBR real-time PCR from the Norwegian material, were sequenced in one direction applying
primer PgMt19 F3 as previously described [16].
Statistical analyses
Statistical univariate analysis was performed applying IBM SPSS Statistics version 24 (SPSS
Inc., IBM Company). The data were organized into categorical variables for 2x2 cross-tabula-
tion analysis, and assessed with effect estimates (odds ratio) with corresponding confidence
intervals, as well as Chi-squared test, or Fisher’s exact test if few observations. A correlation
was regarded as statistically significant if p-value was < 0.05.
Multivariate logistic regression analysis was also performed applying SPSS. The p-values were
calculated by using the Likelihood ratio test, where in addition to SPSS the program QuickCalcs
(GraphPad Software) was applied for this purpose. All variables with p-value <0.1 from the uni-
variate analysis, excluding variables with extensive numbers of missing values, were included in
Table 1. Characteristics of real-time PCR methods.
Methods Specificity Target
genome
Target gene No. copy of gene
in P.f
Product size Species identification by sequencing
This study Pan Mito cytb ~20–160a 220 bp Yes
Lefterova et al. 2015 [21] Pan Chrom 18S rRNA ~5–8b 317 bp Yes
Xu et al. 2015 [22] Pan Mito cytb ~20–160a 430 bp Noe
Farrugia et al. 2011 [23] Pan Mito cytb ~20–160a 203 bp No
Hofmann et al. 2015 [15] P.f Chrom TARE-2 ~250–280c 93 bp -
Hofmann et al. 2015 [15] P.f Chrom varATS ~59d 65 bp -
Abbreviations: P.f, Plasmodium falciparum; Mito, mitochondrial; Chrom, chromosomal; cytb, cytochrome b gene; telomere-associated repetitive element 2, TARE-2;
var gene acidic terminal sequence, varATS.
a Depending on which stage of the parasite cycle; About 20 copies in early ring stage, and about 80–120 copies in mature gametocytes [13, 14].
b Depending on the strain [12].
c TARE-2, specific to P. falciparum, consists of 10 to 12 repeat units presented at 24 of 28 subtelomeric sequences [15].
d The var gene family is located primarily in the subtelomeric sequences, and encode the P. falciparum erythrocyte membrane protein 1 [15].
e Species identification can be performed using restriction fragment length polymorphism analysis of the real-time PCR amplified product [22].
To optimize their comparability, all the real-time assays applied 2 μl DNA template, and 12,5 μl SYBR Select Master Mix/ TaqMan Universal Master Mix II, with UNG
(Applied Biosystems, Carlsbad, CA, USA), at a total volume of 25 μl. The amplifications were performed using ABI Prism 7900HT Sequence Detection System (Applied
Biosystems), the threshold was automatically set, and for the SYBR assays melting curve analysis was included given by the program SDS 2.3 (Applied Biosystems).
https://doi.org/10.1371/journal.pone.0218982.t001
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the multivariate regression model. The confirmation that the model fitted the data was evaluated
by the Hosmer and Lemeshow Test, and by residuals and Cook distances analysis.
Ethical approval
The study was approved by the Regional Committee for Ethics in Medical Research in Western
Norway (No.2015/886 and 2016/584).
Results
All raw data, including threshold, Ct- and quantification values, are given in supporting infor-
mation S1 Dataset. The clinical and field DNA samples were always run in triplicates, and a
positive result was defined as minimum two detections out of three.
Assessment, comparability, and sensitivity of real-time PCR methods
The sensitivity and specificity of the designed and optimized genus-specific cytb SYBR and
TaqMan PCR protocols were assessed applying the Norwegian clinical material. The real-time
assays showed as high sensitivity and specificity as their conventional PCR counterpart [16],
except missing one P. malariae sample (S1 Table).
Applying P. falciparum reference material, the study’s two protocols and five relevant real-
time PCR methods (characteristics presented in Table 1) were compared to investigate how
the choice of platform and amplification target affects the sensitivity (Tables 2 and S2).
Among the five included assays the varATS TaqMan PCR method [15] showed a high sen-
sitivity, and was therefore chosen for further assessment together with the designed cytb
SYBR/TaqMan PCR protocols, applying P.falciparum positive Tanzanian field material
(Table 3). Furthermore, the sensitivity of applying whole blood versus that of using filter paper
as field material was compared, and the difference in Ct trends for the cytb SYBR real-time
PCR results are shown in Fig 1. Among the field samples extracted from whole blood, previ-
ously obtained research microscopy and RDT results were correlated with positive Ct values of
the cytb SYBR PCR as presented in Fig 2.
Through the analysis of both the Norwegian and Tanzanian material, several of the previ-
ously positive DNA samples turned out negative by the real-time PCR methods. Therefore, the
quality of the stored DNA was tested by reanalysing, with the cytb conventional PCR [5, 16,
18], all samples which were negative or had a Ct value above 30 by the cytb SYBR real-time
method. Fig 3 shows a comparison between the conventional and the real-time PCR methods.











This study_cytb SYBR 12 (30) 12 (33) 12 (34) 9 (36) 9 (38)
This study_cytb TaqMan 12 (30) 12 (32) 12 (33) 8 (35) 5 (37)
Lefterova_18S SYBR 12 (28) 12 (32) 11 (34) 4 (36) 0
Xu_cytb SYBR 12 (28) 12 (32) 12 (33) 10 (35) 6 (35)
Farrugia_cytb TaqMan 12 (34) 12 (37) 12 (38) 3 (41) 1 (42)
Hofmann_TARE-2 SYBR 12 (33) 12 (37) 12 (38) 7 (40) 3 (39)
Hofmann_varATS TaqMan 12 (34) 12 (36) 12 (37) 11 (40) 8 (41)
a The threshold was automatically set for each assay run, and the Ct values correspond to the threshold. The results are given as the number of positives out of 12
parallels.
https://doi.org/10.1371/journal.pone.0218982.t002
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The designed cytb SYBR PCR assay showed better results than using TaqMan probe (Tables
2 and 3 and S1 and S2). Therefore this method was chosen for the q-PCR analysis of the Tanza-
nian field material, and to test the quality of sequencing as species identification method. The
sequencing confirmed high-quality sequences of full length, and gave correct species identifi-
cation, except for only detecting the dominating P. falciparum parasitaemia in two double
infections. This result was equal to that of applying the conventional PCR version, and the
polymorphisms distinguishing the species were previously described [16].










Positives Ct < 20 25 20 19
Positives Ct 20–30 16 19 18
Positives Ct 31–40 13 15 24
Positives Ct > 40 0 0 0
Positives total 54 54 61




Positives Ct < 20 0 0 0
Positives Ct 20–30 27 23 26
Positives Ct 31–40 10 11 8
Positives Ct > 40 0 0 1
Positives total 37 34 35
Negatives 0 3 2
Abbreviations: P.f, Plasmodium falciparum
a Predefined samples by genus-specific cytb conventional PCR, and species-specific 18S PCR (or sequencing) [5, 18]. Data on concluding positivity is given in S1
Dataset.
b DNA extracted from 200 μl EDTA whole blood by a spin-column method.
c DNA extracted from filter paper (~50 μl blood) by a Chelex-100 method.
https://doi.org/10.1371/journal.pone.0218982.t003
Fig 1. Ct value comparisons of DNA samples extracted from 200 μl EDTA whole blood versus filter paper 50 μl
blood (N = 37). Positive P.falciparum material from 37 patients had been collected and extracted by two different
methods resulting in DNA from whole blood purified by spin-column, and DNA from filter paper purified by Chelex-
100 [5, 18]. The two Ct trends showed a constant difference of 4–9 cycles, and for 31 out of 37 samples the difference
was 7–9 cycles.
https://doi.org/10.1371/journal.pone.0218982.g001
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Application and assessment of quantitative PCR field data
To present an alternative and relevant application of q-PCR data in epidemiological studies,
the association between low-level parasitaemia identified by the cytb SYBR q-PCR results and
clinical and demographic factors (among the 74 field samples extracted from whole blood),
Fig 2. Boxplots showing how research microscopy and RDT results correlate to positive Ct values among
Tanzanian field samples. (A) A boxplot showing how research microscopy results negative/positive correlate to
positive cytb SYBR real-time PCR results (N = 54). (B) A boxplot showing how rapid diagnostic test (RDT) results
negative/positive correlates to positive cytb SYBR real-time PCR results (N = 47).
https://doi.org/10.1371/journal.pone.0218982.g002
Fig 3. Sensitivity analysis and method comparison of PCR methods applying positive P.falciparum field DNA
samples with extreme low parasitaemia (N = 42). Extreme low parasitaemia samples that counted negative or Ct
value above 30 by cytb SYBR real-time PCR were further analyzed. This was done to investigate if the stored DNA had
been degraded over time, as well as compare the performance of the four PCR methods. The varATS TaqMan real-
time PCR had a higher detection rate for low parasitaemia. However, for all of the methods eight of the previously
positive P. falciparum samples were now negative. A positive sample was defined by at least two out of three parallels
detected, and only one of the eight negatives had no positive detections of parallels by any of the methods. For several
of the samples it was a randomly/non-consistently detection trend, depending on the actual amount of amplification
target in the template. Detailed data are given in S1 Dataset.
https://doi.org/10.1371/journal.pone.0218982.g003
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were evaluated applying cross tabulation and multiple logistic regression analysis. Based on an
evaluation of Ct results, frequency data, and what was of low density parasitaemia (S1 and S2
Datasets), the q-PCR values were categorized into the two categories �1000 copies/rxn
(N = 37, range 0–953, corresponds to Ct value �27) defined as low parasitaemia, and > 1000
copies/rxn (N = 37, range 3769–1.6x107, corresponds to Ct value �24) defined as high parasi-
taemia. The median value was 2361 copies/rxn. When applying 2 μl template, 1000 copies of
the cytb target/rxn, corresponds to 3–25 P. falciparum p/μl depending on the parasite stage
(Table 1). Microscopy had the most sensitive detection at Ct value 23 and 15314 copies/rxn,
which corresponds to ~50–380 p/μl. In comparison, according to Hänscheid et al. 1% parasi-
taemia is measured to be ~50.000 p/μl [25].
In the univariate analysis (Table 4), low-level parasitaemia was associated with age �12
months, illness of >5 days duration, and death while in hospital. Patients with low-level parasi-
taemia were more likely to have received antibiotics the last four weeks, but less likely to have
been diagnosed with malaria, and less likely to have received antimalarial treatment in hospital.
In the multivariate analysis (S3 Table), low level parasitaemia was associated with age �12
months, length of illness >5 days, no history of travel outside Dar es Salaam the last four weeks,
and not being diagnosed with malaria. The variables antibiotic and antimalarial treatment in
hospital were omitted from the regression model due to a high number of missing values.
Discussion
Several studies report that PCR techniques are superior to microscopy, especially in detecting
low density parasitaemia [26–28]. A review of studies comparing PCR and microscopy, found
that PCR detects on average twice as many malaria infections as microscopy [29]. The genus-
specific cytb conventional PCR [16], has previously been applied in studies from Tanzania and
India, where the PCR detected as much as 72% (55/76, N = 304) and 71% (162/228, N = 1168)
submicroscopic malaria respectively [5, 17]. The conversion and optimization from conven-
tional to real-time PCR, using either SYBR green or TaqMan probe, resulted in similar sensi-
tivity and specificity (S1 Table and Fig 3 and S1 Dataset).
Applying SYBR is less expensive than using probes. Though the specificity of SYBR assays
is debated; while probes bind specifically to target DNA as an third oligo, the specificity of
SYBR relies on a high efficiency and concentration of specific amplified DNA outshining the
unspecific binding of SYBR [30]. Short amplicons give higher efficiencies. In contrast to
probes, which release only a single fluorophore for each amplicon, SYBR will with longer
amplicons generate a stronger signal increasing the sensitivity as more dye is incorporated
[31]. This is in agreement with the observed higher sensitivity of the study’s SYBR assay com-
pared to using probe (Tables 2 and 3 and S1 and S1 Datasets). Using SYBR showed 100% spec-
ificity, while the TaqMan assay had one unspecific binding at Ct value 41 (S1 Table). The
SYBR protocol in this study is recommended compared to using TaqMan probe.
Comparing different real-time PCR methods showed that the assays are remarkably similar
in sensitivity (Table 2). The 18S SYBR PCR (Lefterova et al. [21]) had the lowest sensitivity, as
might be expected since the target gene is in only a few copies (Table 1). Surprisingly, the
method using the target in most copies, TARE-2 SYBR PCR (Hofmann et al. [15]), was not the
most sensitive one. However, this agrees with the authors’ report of lower sensitivity than
expected, likely due to the degenerate sequence of the TARE-2 repeat units or by the clustered
distribution of the repeats at chromosome ends. The three most sensitive assays were the var-
ATS TaqMan (Hofmann et al. [15]), the cytb SYBR (Xu et al. [22]), and this study’s cytb SYBR
PCR. The cytb SYBR assay from Xu et al. showed the lowest amplification efficiency (S1
Table), which is in agreement with the authors’ report on a secondary structure of the main
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amplicon that likely contributes to a competing binding-site for the primers, and can affect
optimal sensitivity. This study’s assays, the 18S SYBR (Lefterova et al.), and the cytb SYBR (Xu
et al.), are genus-specific PCR methods which have the advantage of species identification by
Table 4. Univariate cross tabulation analysis of factors associated with low parasitaemia (�1000 copies/rxn).
Low
parasitaemia
� 1000 copies/rxn (%)
High
parasitaemia
> 1000 copies/rxn (%)
OR (95% CI) p-value
Age (N = 73)
� 12 months 17 (47.2) 5 (13.5) 5.73 (1.82–18.04) 0.002�
> 12 months 19 (52.8) 32 (86.5)
Sex (N = 74)
Male 22 (59.5) 19 (51.4) 1.39 (0.55–3.49) 0.483
Female 15 (40.5) 18 (48.6)
Travel outside Dar last 4 weeks (N = 63)
No 19 (65.5) 15 (44.1) 2.41 (0.87–6.69) 0.089
Yes 10 (34.5) 19 (55.9)
Referral from other hospital (N = 71)
No 24 (68.6) 29 (80.6) 0.53 (0.18–1.57) 0.246
Yes 11 (19.4) 7 (19.4)
Antibiotics the last 4 weeks (N = 66)
No 5 (14.3) 15 (48.4) 0.18 (0.06–0.58) 0.003�
Yes 30 (85.7) 16 (51.6)
Antimalarials the last 4 weeks (N = 68)
No 15 (44.1) 11 (32.4) 1.65 (0.62–4.43) 0.318
Yes 19 (55.9) 23 (67.6)
Length of sickness (N = 72)
� 5 days 16 (43.2) 29 (82.9) 0.16 (0.05–0.47) 0.001�
> 5 days 21 (56.8) 6 (17.1)
Antibiotic treatment in hospital (N = 74)
No 2 (5.4) 4 (10.8) 0.47 (0.08–2.75) 0.219
Yes 35 (94.6) 33 (89.2)
Antimalarial treatment in hospital (N = 74)
No 8 (21.6) 1 (2.7) 9.93 (1.17–84.04) 0.008�
Yes 29 (78.4) 36 (97.3)
Given diagnosis malaria (N = 74)
No 22 (59.5) 10 (27.0) 3.96 (1.49–10.53) 0.005�
Yes 15 (40.5) 27 (73.0)
Given diagnosis septicaemia (N = 74)
No 24 (67.6) 32 (86.5) 0.33 (0.10–1.05) 0.053
Yes 12 (32.4) 5 (13.5)
Length of admission (N = 74)
� 5 days 24 (64.9) 20 (54.1) 1.57 (0.62–4.00) 0.343
> 5 days 13 (35.1) 17 (45.9)
Outcome (N = 74)
Dead 11 (29.7) 4 (10.8) 3.49 (1.00–12.24) 0.043�
Alive 26 (70.3) 33 (89.2)
Abbreviation: OR Odds ratio, 95%CI 95% Confidence Interval, Dar Dar es Salaam.
�Significant results (p-value < 0.005).
https://doi.org/10.1371/journal.pone.0218982.t004
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either sequencing or restriction fragment length polymorphism analysis. The TARE-2 and var-
ATS methods are restricted to P.falciparum. In clinical use any of these PCR assays will be sen-
sitive enough; however, in detecting low-level parasitaemia the small differences in sensitivity
might be relevant. Furthermore, amplification in late cycles of PCR programs can be due to
unspecific binding or primer-dimers. However, it was in this study decided to not set a cut-off
for positivity as also low-level parasitaemia has late amplifications (Table 2). Hence the SYBR
methods were more beneficial to apply than TaqMan probes focusing in detecting low-level
parasitaemia, since SYBR melting curve analysis (MCA) can be performed revealing if late
cycle amplifications are unspecific binding or primer-dimers rather than true positives [32].
PCR detects very low densities of target DNA in the blood (S1 and S2 Datasets), and com-
pared to microscopy and RDT, the technique has a superior sensitivity in detecting low-level
parasitaemia (Fig 2). Asymptomatic malaria among PCR positives should always be consid-
ered [17, 33]. To achieve a low detection limit, the type of material is important. Filter papers
are increasingly used in field studies, as the material is easier to collect, store, and transport
than EDTA whole blood, but result in lower test sensitivity due to the smaller blood volume
obtained, ~50 versus 200 μl (Fig 1) [18]. Target DNA extracted from filter papers had in this
study a detection limit of 25 copies/rxn, while DNA from EDTA had 1 copy/rxn. Therefore,
applying filter papers gives a high sensitivity, but a substantial portion of the low-level parasi-
taemia will be missed which might be relevant in surveillance and epidemiological studies.
The P. falciparum positive field material extracted from whole blood (N = 74), showed a
broad variation in level of parasitaemia (Table 3). There is a great complexity of reasons why
malaria DNA detected only by PCR is obtained in the blood stream. Low density of malaria
DNA may derive from early (primary or recurrent) infection, non-falciparum infection (as indi-
cated in S1 Table where a clinical P. malariae infection showed a high Ct value), premunition,
or remains of parasites and denatured DNA after infection clearance by the immune system
and antimalarial treatment. Also some antibiotics may reduce the parasite level in the blood
without fully clearing the infection [34]. Sexual stage parasites (gametocytes) are less affected by
antimalarial drugs and the immune system, and thus circulate in the blood for weeks after para-
site life cycles are ended awaiting transmission [35, 36]. Untreated chronic low-level parasitae-
mia might persist for months as parasite clones can circulate for ~200 days [37].
Due to potentially reduced quality of the stored DNA, and low reproducibility for samples
with extremely low parasitaemia (Fig 3), the field material (N = 111) was also used for sensitiv-
ity assessment of the the designed cytb SYBR/TaqMan and the varATS TaqMan PCR methods.
Compared to DNA extracted from whole blood, the DNA from filter paper showed high stabil-
ity with only a few previously positive samples testing negative (Table 3), which may be caused
by the ion-exchange resin Chelex solution inhibiting DNA degradation by chelating metal
ions that otherwise can catalyze breakdown of DNA [38]. Table 3 also showed that the varATS
assay detected five more positive samples than the cytb SYBR method. With regards to the two
different amplification targets cytb versus varATS, cytb PCR assays should in theory be twice
as sensitive as varATS PCR in detecting gametocytes, while varATS targets should be about
three times as sensitive as cytb in detecting ring stage parasites (Table 1). Therefore, it can be
speculated if a substantial proportion the field samples with low-level parasitaemia are malaria
infections dominated by asexual blood stage parasites, rather than gametocytes.
By applying a customized plasmid, quantitation analysis was performed, and the association
between degree of parasitaemia defined by q-PCR values (N = 74) and clinical and demo-
graphic features was assessed (Tables 3 and S3). The study population was children <5 years.
Children have a less developed immune system than adults, though antibodies from their
mother and in breastmilk give some protection in their first months of life [39, 40]. Both the
univariate and multivariate analysis found a significant correlation between age �12 months
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and low parasitaemia, which could be due to immunity and asymptomatic malaria in this
group. Among children age �12 months, 37% (7/19) had received antimalarials within four
weeks of admission, versus 71% (34/48) among children age >12 months (S2 Dataset). Fur-
thermore, in the univariate analysis, low parasitaemia was significantly associated with death
in hospital (Table 3), though not significant in the multivariate analysis (S3 Table). The associ-
ation is counter-intuitive, as high parasitaemia is known to be a risk factor for death. However,
low parasitaemia malaria may be wrongly interpreted as clinical malaria obscuring the diagno-
sis of other severe blood stream infections. In a previous study from the same hospital, blood-
stream-infections caused by multi-resistant Gram-negative bacteria carried case-fatality rates
(>70%) more than three-fold that of malaria (�20%) [41]. The finding that patients with low-
level parasitaemia less frequently had been given a diagnosis of malaria, and less frequently
had received antimalarial treatment, support that other infections may have been the cause of
disease and mortality in these children, or might indicate missed opportunity for treatment of
early malaria infection. The DNA detected by PCR can stem from a recent malaria episode for
which the patient had already received treatment and recovered from. Indeed, children who
have recently been hospitalized with malaria and anemia have substantially increased risk of
death in the subsequent months [42, 43]. Among the children 81% (51/63) had received either
antibiotics 70% (46/66), antimalarials 62% (42/68), or both 46% (29/63), within four weeks
prior to admission (S2 Dataset). A limitation to the q-PCR assessment is the small sample size
and the limit age-interval (children <5 years), as well as few clinical parameters. The samples
used in the assessment had been collected in order to perform malaria PCR, but for a different
purpose and application (Strøm et al. investigating challenges in diagnosing paediatric malaria
[5]). Therefore, to assess predictors of clinical outcome in low-parasitaemia, this alternative q-
PCR approach should be applied in larger, prospective studies employing comprehensive diag-
nostics for the major relevant differential diagnoses of acute undifferentiated febrile illness,
including blood culture and serology for rickettsia and viral infections. Furthermore, since an
unknown portion of the low parasitaemias probably is due to gametocytes, methods detecting
mRNA specifically produced by gametocytes could be relevant to include increasing knowl-
edge around transmission dynamics [44].
Stored DNA is commonly used in PCR assessments and analysis, since extracted DNA is
regarded as a fairly stable material if kept in a freezer [45]. It has been debated if freezing and
thawing of samples can have a denaturing effect on the DNA [46]. The quality of the stored
DNA in this study was tested by reanalyzing the samples with the cytb conventional PCR used in
the first analyses of the Tanzanian field material [5]. The results indicated that the DNA might
have been degraded over time (Fig 3 and S1 Dataset), which, is a possible bias to the correlations
shown in Fig 2 and Table 4. However, Fig 1 demonstrates the accuracy and consistency of PCR,
and shows no indication of denatured DNA in samples with high parasitaemia. For samples with
extremely low parasitaemia, reproducibility by PCR is challenging (Fig 3 and S1 Dataset). The
number of times each sample was defrosted varied due to testing, therefore some samples might
have been more prone to degradation than others (S1 Dataset). Since all the 74 samples assessed
with q-PCR were previously confirmed positive by PCR (data on concluding positivity is given
in S1 Dataset), it was decided in regards to the patient data that also q-PCR results with value
zero should be included in the definition of low parasitaemia (�1000 copies/rxn).
Conclusions
Choice of amplification target applied in real-time malaria PCR is relevant for achieving high
sensitivity, especially in detecting low-level parasitaemia. Furthermore, it is advantageous to
use an intercalating fluorescence dye suitable for MCA rather than labelled hydrolysis probes.
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Application of q-PCR analysis should be included in epidemiological studies, and may increase
awareness and understanding of low-level parasitaemia. The highly sensitive, specific, and
user-friendly cytb SYBR q-PCR developed in this study can be useful in both epidemiological
and clinical malaria studies. The method is genus-specific, which is an advantage in large
screening projects. Among ambiguous samples, and in settings where species-specific PCR
fails to detect low parasitaemia, confirmation and species identification by sequencing of the
genus-specific real-time PCR products can be used as a contingency.
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